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Glioblastoma (GBM) is a highly invasive brain cancer characterized by poor prognosis. 
Despite significant efforts by the basic and clinical research community our 
understanding of GBM progression and recurrence has been incremental. Improvements 
in therapeutic response have been dismal, and GBM continues to be the deadliest tumor 
of the central nervous system, with patient average survival rate of 12 months. 
Synergistic relationships that the tumor cells establish with the brain microenvironment 
have been proven fundamental for successful tumor progression and maintenance. Yet, 
many in vitro GBM studies are performed in formats that fail to recapitulate the most 
essential component of the tumor microenvironment.  
 
In this work we aim to describe the influence of multiple features of the tumor 
microenvironment on GBM migration characteristics and response to drug treatment. Our 
approach involved the development of a 3D in vitro tissue model that recapitulates the 
cellular, chemical and mechanical features of brain microenvironment. To assess the 




we developed a matrix of hyaluronan supported by collagen with embedded microfibers 
to simulate the composition of brain ECM and the topographical cues of vasculature. 
Comparison of this model with Matrigel and collagen type-I showed that GBM exhibits 
different migration modes such as collective expansion, multicellular strands, and single 
cell migration as a response to the ECM composition and stiffness. Further incorporation 
of brain stromal cells as astrocytes and endothelial cells into the model showed that 
presence of astrocytes increased the migration of all GBM cell lines studied, however 
presence of endothelial cells only increased the migration of glioblastoma stem-like cells. 
Evaluation of the cytotoxic effect of multiple drugs on GBM was performed using our 3D 
model. Presence of extracellular matrix and stromal cells reduced the sensitivity of stem-
like GBM cells to drug treatments. Our specific focus was on anti-STAT3 therapy and 
data obtained in the 3D model showed that the microenvironment regulates STAT3 
activation as well as response to STAT3 drug targeting.  
 
This work supports the fundamental role of the 3D-microenvironment as a modulator of 
GBM behavior and provides a consistent and tunable in vitro platform to be used in GBM 







CHAPTER 1. INTRODUCTION  
1.1 Objective 
 
This thesis aims to contribute to the understanding of the tumor microenvironment as a 
modulator of glioblastoma migration and drug response. To this end, we sought to bridge 
conventional cancer cell culture and animal models by developing a tunable 3D platform 
that recapitulates in vitro the physical, compositional and cellular components of 
glioblastoma microenvironment. This model offers a more realistic platform to study in 
controlled fashion the influence of some components of the glioblastoma 






Glioblastoma (GBM) is the most common type of glioma and the highest grade. GBM is 
the type of cancer that former American Society of Clinical Oncology president George 
Sledge labeled as “smart”, due to the vast mutations acquired during progression, and the 
ability to rapidly invade healthy brain parenchyma.1
 
Advances in medical treatments have 
demonstrated only minimal improvement of GBM patient’s survival. Usually, less that 5% 
of the patients reach a 5-year survival milestone.2
 
Tumor heterogeneity, resistance to 
treatment and diffuse infiltration into healthy tissue are the most relevant factors involved 
in GBM resistance to treatment. Such aggressive characteristics are closely connected to 
a synergistic relationship between the tumor cells and the microenvironment that allows 
GBM to successfully adapt, grow and invade, 
Failure to include important features of the tumor environment in early in vitro studies is 
a significant consideration of why in vitro results are rarely translational to in vivo 
outcomes. A critical barrier in GBM studies is the lack of in vitro platforms that 
effectively represent the complexity offered by the microenvironment in terms of 
dimensionality, physical, and cellular properties. Most cancer studies are performed in 
liquid platforms that do not represent multi-cellular, microenvironment-mediated 
responses and have limited predictive capability. Although, xenograft models have been 
preferred in advanced studies to offer in vivo characteristics, their complexity limits 





Tissue engineering is an excellent tool that provides a multidisciplinary approach for in 
vitro GBM studies. The use of tunable matrices that closely represent the main 
characteristics of tumor microenvironment, such as the presence of the extracellular 
matrix and stromal cells in controlled contextual situations can provide excellent 
platforms to better understand GBM hallmarks such as invasion/migration, and drug 
resistance. 
1.3 Thesis Overview 
 
This work focused on developing and implementing a controllable 3D in vitro platform 
similar to the GBM microenvironment to bridge existent traditional models and offer 
deeper insights into the overall influence of components of the microenvironment such as 
extracellular matrix and presence of stromal cells on fundamental aspects of GBM such 
as survival, migration and drug response.  
The tumor microenvironment is a fundamental contributor to tumor initiation, proliferation, 
resistance and metastasis and is comprised by three main components: the extracellular 
matrix, stromal cells and tumor cells. The engineered in vitro 3D model developed 
recapitulates the brain tumor microenvironment by incorporating cell-matrix and tumor 
cell-stromal cell interactions as well as biophysical clues from tumor niche. By using the 
model as a tool, we focused on the influence of two major components of tumor 
microenvironment, namely, the extracellular matrix and stromal cells on GBM migration 
and drug response. The transversal contributions result of this work that are individually 




of the tumor microenvironment, 2) The role of the physical properties of the extracellular 
matrix (ECM) during glioma migration, 3) Influence of extracellular matrix and stromal 
cells presence on GBM drug-response, 4) Influence of dimensionality and presence of 
stromal cells on GBM migration and 5) The effect the 3D GBM microenvironment as a 
regulator of STAT3 activation and response to drug inhibition.  
The first chapter presents introductory background remarks on the characteristics of 
GBM, the importance of migration as a characteristic feature of GBM, the importance of 
tumor microenvironment as a modulator of tumor progression and a brief overview of the 
advances in the development of in vitro models that mimic the GBM microenvironment. 
The second chapter sheds light onto the regulation of GBM stem cell migration 
characteristics by different properties of 3D extracellular matrix (ECM) such as 
composition and stiffness. The brain ECM differs from other organs in composition and 
mechanical properties due to absence of rigid proteins and high presence of hyaluronan. 
Given the fundamental role migration on GBM relapse, we determined how stiffness, 
composition and topography of the ECM alter 3D-migration of GBM stem-like cells 
(GSCs). The results revealed that GSCs exhibit different migration modes such as 
collective expansion, multicellular strands, and single cell migration as a response to the 
ECM composition and stiffness. The development and evaluation of a model of brain-like 
ECM model showed that increasing concentrations of hyaluronan reduce migration and 
presence of structural cues induce changes in migration mode of GSCs, therefore 




The third chapter describes the influence of the microenvironment on survival of GBM 
after drug treatment. We increased the complexity of our previously developed 3D model 
of the GBM extracellular matrix by incorporating brain stromal cells such as astrocytes 
and endothelial colony forming cells (ECFCs). The model was used as a predictor of 
therapeutic response in various patient-derived GBM cell lines. Presence of the 3D 
extracellular matrix decreased the cytotoxic effect of multiple drugs on GBM stem-like 
cells compared to liquid culture. Also, presence of stromal cells into the 3D model 
decreased the effect of single and combination drug treatment on GBM stem-like cells, 
however their presence did not influence the sensitivity of non-stem GBM cells to the 
same extent. 
 
In the fourth chapter we determined the effect of presence of extracellular matrix and 
stromal cells such as astrocytes and endothelial cells on GBM migration. We concluded 
that presence of stromal cells in the 3D environment increases the migration of GBM 
stem-like cells. However, only astrocytes and not ECFCs increase the migration of non-
stem GBM cells. 
The last research contribution described in Chapter 5 investigates the effect of the 3D 
microenvironment on the basal activation of STAT3, a master regulator of multiple 
oncogenic processes, and on STAT3 inhibition by the small molecule SH-4-54. 
Preliminary results show that presence of the 3D ECM induces basal activation of 
STAT3 in GBM, including cell lines that did not show basal activation when cultured in 
liquid platform. Also, the presence of the 3D brain-like ECM influences the effectiveness 




1.4 Introductory Remarks on Glioblastoma and the Tumor Microenvironment 
 
1.4.1 Characteristics of Glioblastoma 
 
Glioblastoma (GBM) is a malignant astrocytoma grade IV that presents a poor prognosis 
and overall median survival of 15 months.2 GBM is characterized by diffuse and rapid 
infiltration across healthy brain parenchyma, neovascularization of the neighboring 
microenvironment and presence of necrotic sections within the tumor mass.3 Almost 
invariably GBM reappears in surrounding tissue after treatment by surgical resection, 
radiation, and chemotherapy. Advances in medical treatments have demonstrated only 
minimal improvement in GBM patient’s survival with less than 5% of the patients 
reaching a 5-year survival milestone.2   
A common characteristic of GBM tumors is the rapid neovascularization reached through 
paracrine signaling with vascular endothelial cells and in some cases through direct 
differentiation of GBM stem-like cells into vascular cells.4–6 GBM tumors are also 
characterized by presence of a hypoxic niche as a result of rapid proliferation of tumor 
cells. Although the dual presence of a perivascular and hypoxic niche seem contradictory, 
hypoxic signals prompt vasculature formation, however rapid vascularization is achieved 
by formation of blood vessels that provide irregular oxygen supply to the tumor, where 
hypoxic sections arise. 
The rapid infiltration into healthy tissue and heterogeneity of recurrent GBM have been 




features termed glioblastoma stem cells (GSCs). GSCs are classified as cells that reside in 
tumor mass and share characteristics with normal neural progenitors cells such as 
expression of stem markers (mainly CD133-prominin), self-renewal abilities, formation 
of neurospheres, and ability to differentiate into all cells of neural origin (astrocytes, 
neurons and oligodendrocytes).7 Although the concept of GSCs has been debated mainly 
due to the lack of reliable set of markers, studies have demonstrated that GBM is one of 
several cancer types with a relative consistent presence of cancer stem cells.8 As few as 
100 GSCs CD133+ have the ability to repopulate a complete new tumor after 
transplantation into a host.9 
Given the tumor reappearance both, in the vicinity and in distant locations of the primary 
mass, it is hypothesized that GSCs have a high migratory ability and greater intrinsic 
mechanisms to resist and adapt to chemo- and radio therapy compared to non-stem GBM 
cells.4,10 Moreover, the plasticity of GSCs to undergo genetic changes and differentiate 
into multiple lineages cells4,6,11,12 is associated with the creation of a special niche that 
harbors this population and acts as a feedback loop to provide the conditions required for 
stemness maintenance. Normal neural stem cells reside mainly in specific locations of the 
brain as the subventricular zone (SVZ) and the subgranular zone, that provide direct 
contact with multiple cells required to support their niche, particularly, vascular networks 






1.4.2 Migration as a Hallmark of Glioblastoma 
 
Malignant gliomas as GBM present diffuse and aggressive invasion of healthy brain 
tissue. GBM can successfully and rapidly invade any part of the brain, regardless of the 
distance to the primary tumor, yet, unlike other cancers rarely intravasates and 
metastasizes to other organs. The infrequent cases of extracranial metastasis are usually 
observed in lungs, liver, lymph nodes and bone marrow and are associated with surgical 
intervention of the primary mass such as biopsy and resection. Occurrence of GBM 
metastasis without prior surgical intervention in the patient has been reported, however 
these cases are extremely uncommon.   
Successful and directional migration of GBM has been associated with the ability of the 
tumor cells to recapitulate some migratory features of neural cell progenitors during 
cortical development.13,14 GBM preferentially migrates along preexisting tracks such as 
myelinated axons in the white matter and the basement membrane (BM) surrounding the 
vasculature as histopathological examination has shown.14 This pattern of invasion 
suggests the presence of productive infiltration mechanisms mediated by the brain 






Figure 1.1 Main migration routes of glioblastoma (GBM) are axonal tracks and blood 
vessels  
 
Cell migration requires a complex coordination of multiple processes that involve 
reciprocal signaling and communication with the microenvironment including the 
extracellular matrix, stromal cells and other components of the tumor mass. GBM 
directly remodels the microenvironment extracellular matrix by depositing 
glycosoaminoglycans, proteoglycans as well as other molecules that are not normally 
present in neural ECM. For instance, fibrillar collagen, absent in neural ECM has been 
detected in GBM both intra and extra-tumorally,15,16 suggesting its deposition by tumor 
cells presumably to increase the stiffness of normal tissue as a way to facilitate migration. 
Similarly, the extracellular matrix of some high-grade gliomas such as GBM presents 
fibronectin, yet, similar to collagen; fibronectin is not a component of healthy brain ECM. 
Fibronectin deposition has been associated with increased activity transcription factor 
NF-kB in GBM cells through a process associated with uPA/uPAR activation17 and 








the extracellular matrix by glioma ultimately has the function of generating an 
environment more suited for the needs of the cancer cells such as migration and adhesion. 
Other components of the microenvironment such as stromal cells are also fundamental 
contributors of GBM migration. Paracrine signaling between tumor cells and stroma 
affect tumor migration, as has been thoroughly reviewed by Hoelzinger (2007) and 
Placone (2016). Additionally, recent studies have shown that microglia, the brain resident 
macrophages, contribute to tumor migration by both, increasing GBM expression of 
matrix metalloproteinases such as MMP-219 and secreting pro-inflammatory cytokine IL-
18.20 Secretion of glial-derived neurotrophic factor (GDNF)21 and TGF-β by astrocytes 
triggered by interaction with tumor cells has also been shown to increase GBM migration. 
Beyond the widely studied role of paracrine signaling GBM migration, physical contact 
between tumor and stroma also has a profound impact on the ability of tumor cells to 
successfully migrate. Physical interaction between tumor cells and vasculature in a 
process denominated vessel cooption is one of the earliest mechanism by which the 
tumor cells reach “vascular highways” to migrate. During co-option GBM cells target 
pericytes on the existing vessels by developing specialized protrusions called flectopodia. 
The physical communication established between the two cell populations is transient 
and occurs prior tumor neovascularization.22 Similarly, increased expression of the gap 
junction protein connexin-43 in glioma cells has been linked to increased migration 
mediated by intercellular gap junction communication between the tumor and astrocytes 
as well as intercellular transference of microRNA-5096 and microRNA-4519, both 




The relationship between migration and microenvironment is reciprocal and dynamic. 
Along with interactions tumor-stroma and the effect of glioma on remodeling the 
extracellular matrix, the existing microenvironment also modulates the migration 
strategies adopted by cells. The adaption of cancer cell migration mode in response to 
different microenvironments has mainly been observed in 3D in vitro constructs. 
Observations of breast cancer cells switching from collective spheroids in basement 
membrane-like matrices to mesenchymal single migration in collagen matrices25 or GSCs 
switching from single cell migration in collagen to a multicellular stream migration when 
faced with topographical clues that mimic blood vessels26 are examples of the influence 
of the physical microenvironment on motility. Despite great advances understanding the 
influence of diverse physical cues on migration, how biological and physical factors 
interplay to determine a preferential migration strategy remains to be understood. 
Previous studies have linked the ECM properties like matrix elasticity with the 
polarization of regulators of cell migration such as Rho family GTPases. Petrie (2012) 
showed that elastic behavior of the ECM, induces specific polarization patterns of the 
Rho GTPases Rac1 and Cdc42 governed by RhoA, ROCK or myosin II activity.27 
Recently, Mertsch (2013, 2014)28,29 showed that ROCK1 mediates substrate-dependent 
GBM migration and its inhibition decreases the ability of GBM to recognize different 
types of ECM and show preferences for specific ECMs to migrate.  
The specific role of the multiple physical and chemical signals that the brain 




its infancy. However, elucidating such interactions is fundamental to understand the 
dynamics of brain cancer progression. 
 
1.4.3 Role of the Tumor Microenvironment in Glioblastoma Progression 
 
The influence of the microenvironment as a regulator of cell response has been 
increasingly recognized. Cell behavior is not only dependent of genetic instructions but is 
equally modeled by the external signals from the microenvironment. Specifically in 
cancer, such regulation reaches a higher level of complexity and reciprocity due to the 
active remodeling exerted by the cancer cells on the microenvironment. Cancer cells 
modify factors such as pH and nutrients availability and recruit supporting stromal cells30 
to recreate a new niche commonly referred as tumor microenvironment that works as a 
support network to foster tumor survival and resistance. Tumor microenvironment is 




Figure 1.2 Components of the glioblastoma tumor microenvironment. Other cells native 
to brain tiusse and also associated to the tumor microenvironment such as 




The normal brain microenvironment presents distinctive characteristics compared to the 
majority of other tissues. Brain ECM is a low stiffness, loosely connected network 
mainly comprised of hyaluronan, a non-sulphated glycosoaminoglycan with high water-
binding capacity, proteoglycans and Tenascin R and has no presence of rigid proteins 
such as type I collagen or fibronectin.31 Other fundamental differences of brain 
microenvironment that contribute to the uniqueness of brain cancers as GBM are: the 
presence of a different immune defense comprised mainly by microglia, that is also 
recruited to help tumor survival,32 and the existence of the blood brain barrier (BBB), 
formed by astrocytic end-feet lining the surface of the blood vessels, which prevents 
larger, hydrophilic or large molecules including chemotherapy agents to successfully 
reach the brain parenchyma.33 Additional to the unique features of brain ECM, GBM 
dynamically remodels the native ECM to better suit the needs of the tumor during 
progression generating an extracellular matrix distinctive to the tumor that differs in 
composition and mechanical properties to the healthy brain ECM. 
 
Stromal cells present on the surrounding or specifically recruited by the tumor are 
another important component of the tumor microenvironment and well-established 
modulators of cancer growth. One of the most studied stromal cells present in GBM 
microenvironment are endothelial cells, recruited by GBM to vascularize the tumor and 
contribute to both, maintenance and invasion.4,7,34 Endothelial cells are recruited by GBM 
though a mechanism that involves the generation of a hypoxic niche, product of rapid and 
uncontrolled tumor proliferation, that releases proangiogenic signals and triggers the 




a source of nutrients and oxygen but also a permissive route that guides migration and 
enhances the development of distant satellite tumors.  
Likewise, astrocytes and microglia are important players during formation of GBM 
microenvironment. Astrocytes are the main non-neuronal cell of the brain and comprise 
nearly 50% of brain total volume.38 Presence of GBM cells have shown to induce 
astrogliosis in astrocytes adjacent to the tumor,38–40 by a process that recapitulates the 
astrocytic response to brain injury. Astrogliosis induced secretion of pro-inflammatory 
signals supports GBM migration and proliferation and acts as a protection barrier to 
immune surveillance, mainly by T-cells.41 
Microglia are the immune cell residents of brain and account for nearly 10-20% of all the 
brain glia population. After injury or damage, microglia acquire an “activated phenotype” 
that corresponds to increase proliferation, migration, cytokine release and production of 
oxygen reactive species.42 During formation of GBM microenvironment microglia 
heavily infiltrate the tumor mass and despite their role as macrophages do not contribute 
to reduce the tumor progression as it was initially hypothesized. Instead, an increasing 
number of studies suggest that microglia resident in the tumor microenvironment 
contribute to tumor maintenance and immune response suppression.42 Tumor associated 
microglia can help ECM remodeling and tumor migration by secretion of matrix 
metalloproteinases and growth factors.  Yet, tumor resident microglia have a reduced 
ability to induce anti-tumor T-cell response, likely due to tumor repression of microglia 





Finally, the third component of the tumor microenvironment are the tumor cells, and despite 
the plain relationship of tumor cells with the tumor microenvironment, is important to note 
that the heterogeneity of many GBM tumors and dynamic changes in tumor population are 
fundamental for the constant remodeling of the tumor microenvironment. The rapid 
development of new satellite tumors in GBM and resistant to treatment has directly related to 
the presence of a subpopulation of tumor cells with stem cell-like features termed 
glioblastoma stem cells (GSCs). GSCs are classified as cells from the tumor mass that share 
characteristics with normal neural stem cells such as expression of stem markers (mainly 
CD133-prominin), self-renewal abilities, formation of neurospheres, and ability to 
differentiate into all cells of neural origin (astrocytes, neurons or oligodendrocytes).7 
Although the concept of GSCs has been debated based on the lack of a reliable set of markers, 
studies have demonstrated that GBM is one of several cancer types with a relative consistent 
presence of cancer stem cells.8 As few as 100 GSCs CD133+ have the ability to repopulate a 
complete new tumor after transplantation into a host.9  
Given the appearance of new tumors both, in the vicinity and in distant locations of the 
primary mass, it is hypothesized that GSCs have a high migratory ability and greater intrinsic 
mechanisms to resist and adapt to chemo- and radiotherapy compared to non-stem GBM 
cells.4,10 Moreover, the plasticity of GSCs to undergo genetic changes and differentiate into 
multiple lineages cells4,6,11,12 is associated with the creation of a special niches with the tumor 
microenvironment that harbor this population and acts as a feedback loop to provide the 
conditions required for stemness maintenance. In a similar fashion to neural stem progenitors, 
GSCs are thought to reside in locations similar to subventricular zone (SVZ) and the 
subgranular zone that provide direct contact with multiple cells required to support their 




GSCs require specific features in their microenvironment. A common characteristic of GBM 
tumors with presence of GSCs is the presence of a perivascular niche reached. Such vascular 
niche is product of the rapid neovascularization triggered by recruitment of vascular 
endothelial cells and in some cases by GSCs differentiation into vascular forming cells.4–6 
Tumor presenting GSCs also can contain a hypoxic niche as a result of rapid proliferation. 
Although the concomitant presence of a perivascular and hypoxic niche might seem 
contradictory, hypoxic signals prompt vasculature formation; yet, the rapid vascularization of 
the tumor results in leaking blood vessels and irregular oxygen supply giving rise to hypoxic 
sections within the tumor.  
Given the reciprocal relationship between the tumor and its microenvironment, understanding 
GBM not as a sole aggregation of cells with certain genetic mutations but as a self-regulating 
entity comprised by multiple factors besides the tumor cells might offer new directions to 
target more effectively this disease. 
1.4.4 3D in vitro Models of Glioblastoma Microenvironment 
 
Regular studies of GBM are typically performed using 2D monolayer culture on surfaces 
such as glass or plastic, sometimes pretreated poly-l-lysine to increase cell adhesion or 
covered with a thin layer of collagen or laminin to incorporate certain components of the 
extracellular matrix during tumor culture. Studies using 2D liquid culture have 
contributed with seminal results in the overall understanding of GBM; yet, liquid culture 
has restricted versatility in terms of recapitulating the physiological features of the tumor 




microenvironment studies is the effect of a rigid planar surface on cell movement. First, 
because planar surfaces restrict the motility of cells to two dimensions and second, 
because allow the development of cell contacts with a substrate that much more rigidity 
and stiffness than any brain region. During 2D culture cells have a rapid and 
homogeneous accessibility to nutrients in the media. Contrastingly, in real tissues the 
presence of a 3D ECM generates a gradient of nutrients and oxygen that modulates tumor 
processes such as proliferation and recruitment of stromal cells.    
Motivated by the need of better models to recapitulate the physiological conditions of 
GBM microenvironment, various authors have approached the generation of 3D culture 
platforms to recapitulate in vitro the GBM microenvironment. However, most of these 
studies have focused solely on the interaction glioma-ECM overlooking the importance 
of tumor-stroma interactions.  
Diverse approaches have been developed to better simulate the tumor and tumor 
microenvironment, and can be classified into two main groups: scaffold-based and 
spheroid liquid-based 3D models. Controversy exists as to which recapitulates more 
precisely in vivo settings; yet, both approaches have advantages and disadvantages 
depending on the type of study performed. A combination of both, spheroids in scaffold-
based platforms seem to be one of the best approaches, but can difficult the convenience 
for high-throughput studies. 
Initial studies of GBM in 3D platforms were performed in collagen I or Matrigel matrices, 
however, a main drawback of in these models was the lack of similar composition to the 




incorporate hyaluronan, Ananthanarayanan (2011)43 and Pedron (2013)44 developed 
chemically functionalized hyaluronan (HA) matrices to study GBM. Their data reflect 
similar responses to in vivo studies; yet, to achieve a crosslinking matrix, hyaluronan 
needs to be chemically modified and such modifications naturally absent in vivo can alter 
tumor-ECM interaction. Similarly, as a attempt to better recapitulate the presence of 
hyaluronan in glioma 3D models, Yang (2011)45 and Rao (2013)46 generated collagen-
HA matrices, however, these studies used pepsin-treated collagen, a collagen that have 
lost the collagen telopeptides required to form covalent crosslinks and therefore does not 
reflect the architecture and mechanical properties of in vivo structures.45–47 
New approaches to better mimic GBM microenvironment need to be developed. The 
work presented here aims to contribute to the field by introducing a tunable 3D model 
that recapitulates the composition of the GBM microenvironment and also incorporates 
stromal cell populations to generate a model physiologically more relevant for in vitro 
studies. 
Still, many challenges lie ahead in order to have a better approximation the in vivo tumor 
microenvironment. Among the more relevant tasks is the incorporation of tissue 
compositional and physical heterogeneities present in different regions of the brain. Also, 
the ability to generate a model with similar cell density and number of cell types as the 
tumor microenvironment as well as cell-ECM ratio similar to native tissues. Currently, 
3D matrices present limitations in the cell number possible to incorporate due the matrix 
retraction and deformation caused by cell forces. The use of spheroids within 3D ECM as 




the formation of oxygen and nutrient gradients. Nevertheless, accurate assessment of 
metabolic rate and survival can be challenging in these models especially in the event of 























CHAPTER 2. GRATION OF GLIOBLASTOMA STEM CELLS IS MODULATED BY 
THE PROPERTIES OF THE EXTRACELLULAR MATRIX  
2.1 Introduction  
 
Glioblastoma (GBM) is a highly invasive and lethal brain cancer. GBM resistance, rapid 
growth and propagation have been linked to the presence of a subpopulation of tumor 
cells with stem cell-like features termed glioblastoma stem cells (GSCs).8,48–52 Given the 
aggressiveness of GSCs, it has been hypothesized that these cells drive the invasion into 
healthy brain tissue and contribute to regrowth of a new heterogeneous tumor.  
 
It is now well established that tumor cell invasion and maintenance of tumor stem cells 
are processes regulated by the microenvironment and involve specific interactions with 
the extracellular matrix (ECM).53–55 Healthy brain ECM has a distinct composition 
relative to other tissues and organs. It represents a low stiffness, loosely connected 
network comprised mainly of hyaluronan.31,56 In cases such as glioma development, 
tumor cells actively remodel their microenvironment by depositing its own ECM, 
including type-I collagen as a component of the tumor tissue, the surrounding peritumoral 
environment,15 and the GSCs niche.57 GBM can successfully invade any part of the brain, 
yet, unlike other cancers rarely metastasizes to other organs. During invasion, migratory 




matter and basement membrane (BM) surrounding blood vessels.14 Such specific 
invasion pattern suggests the existence of productive infiltration mechanisms mediated by 
the brain specific microenvironment that foster tumor expansion.31,58 
 
Despite the well-known characteristics of brain microenvironment and glioma invasion 
routes, there is still a lack of understanding about the mechanistic migration processes 
exhibited by GBM cells and specifically by GSCs.59 A critical barrier in the cancer field 
is that most of the invasion and migration studies are conducted using 2D substrates that 
fail to recapitulate the dimensionality, composition and physical properties of brain 
tissue.60 Consequently, 3D in vitro models that mimic multiple features of the tumor 
microenvironment and allow the study of important cancer cell subpopulations such as 
GSCs, are required to complement in vivo models and histopathological analysis. 
 
In this study we recreated the one of main features of the GBM microenvironment, the 
extracellular matrix, by developing a tunable 3D matrix with similar composition to 
GBM ECM with incorporated topographical tracks that simulate the brain vasculature, to 
study over time the migratory behavior of GSC neurospheres by using the GBAM1 
(CD133+) cell line. The composite matrix consisted of a hyaluronan network structurally 
supported by a customizable collagen-oligomer fibril matrix embedded with BM-coated 
microfibers to provide alternative migratory paths as occurs in vivo. For comparison, we 
generated reconstituted matrices from the most common 3D cell culture substrates, type-I 
collagen monomers and Matrigel. To account for differences in molecular composition 




prepared matrices with diverse structural and mechanical properties using commercial 
monomeric collagen (BD Biosciences), atelocollagen and oligomeric collagen. We 
cultured the GSCs (GBAM1) neurospheres in the different matrices and monitor 
overtime how fundamental migratory behavior such as migration mode, velocity, 
maximum distance and morphology exhibited by GSC neurospheres was regulated by the 
compositional and physical properties of the different matrices.  
 
 
2.2 Experimental Section  
 
2.2.1 Maintenance of GBM cell line 
GBM cells isolated from human surgical tumor specimens sorted by FACS for CD133 
expression (GBAM1) were kindly provided by Dr. Phillip Tofilon and the Moffitt Cancer 
Center. GBAM1 cells were maintained in stem liquid media DMEM/F12 supplemented 
with B27 without vitamin A (Life Technologies, Carlsbad, CA) and with growth factors 
EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ), at 37°C in an atmosphere of 5% 
CO2. Cells were propagated in T25 or T75 flasks and fed with complete media every 
other day. Neurospheres were disaggregated with TrypLE (Life Technologies, Carlsbad, 
CA) and passaged every 7 days.  
 
2.2.2 Synthesis of collagen matrix 
3D collagen matrices were generated using rat tail type-I collagen monomers from BD 
Biosciences (San Jose, CA), pig skin type-I collagen oligomer,61 and pig skin type-I 




neutralization with 10X PBS (1X PBS has a 0.17M total ionic strength) and 0.1N sodium 
hydroxide to reach pH 7.4. During and after neutralization all reagents were maintained 
at 4°C, the neutralized collagen solutions were pipetted at volumes of 100 µl in 96 multi-
well plates and polymerized at 37°C during 30 min.  
 
2.2.3 Development of a brain-like extracellular matrix 
To generate the composed oligomer-hyaluronan matrices, sodium hyaluronate of 
molecular weight between 351-600 KDa (Lifecore Biomedical, Chaska, MN) was 
dissolved in 10X PBS and added during neutralization of the oligomer to attain final 
concentrations of 2 mg/ml oligomer and 2, 5 and 10 mg/ml hyaluronan. To mimic the 
topography generated by the blood vessels in the brain parenchyma, pseudo-vessels were 
recreated using sterile rods of PDS II- polydioxanone of diameter 100-150 µm (Ethicon, 
Blue Ash, OH) coated with Matrigel by immersion. The coated rods were incubated at 
37°C for 30 min and immersed in the oligomer-hyaluronan matrix prior polymerization. 
 
2.2.4 Cell culture in 3D matrices 
GBAM1 cells were cultured in complete liquid media for 4 days. Neurospheres were 
embedded in each of the matrices (Matrigel from BD Biosciences, collagen and collagen-
hyaluronan) prior polymerization to achieve a density of 1-2 neurospheres per 100 µl of 
polymeric suspension. Volumes of 100 µl of cell-matrix suspension were platted into 96 
well plates. The matrices were polymerized at 37°C for 30 minutes and 100 µl of 





2.2.5 Analysis of mechanical properties 
Rheological properties of the matrices were measured by oscillatory shear in a stress-
controlled AR2000 rheometer (TA Instruments, New Castle, DE, USA) using a parallel 
plate geometry (40 mm diameter). Each sample (1 ml) was polymerized at 37°C on the 
rheometer during 30 min, the geometry was set at 725 µm gap distance and humidity was 
maintained by a solvent trap as previously described.61 The viscoelastic properties, shear 
storage modulus (G’) and shear loss modulus (G’’) were determined by a strain-stress 
sweep from 0.01 to 0.4% at 1 Hz (this range was chosen from predetermined linear-
viscoelastic response regions). All measurements were conducted on at least three 
independent samples. 
 
2.2.6 Immunofluorescence staining 
For detection of N-cadherin in Matrigel matrices, neurospheres were fixed with 4% 
glutaraldehyde, permeabilized with 0.5% triton X-100 (Sigma-Aldrich, St. Louis, MO), 
blocked with 5% BSA (Life Technologies, Carlsbad, CA) in PBS and incubated with 
primary N-cadherin antibody (Santa Cruz Biotech, Santa Cruz, CA) (dilution 1:40) at 
4°C for 12 h followed  by washing and incubation with secondary antibody tagged to 
Alexa-488 (Life Technologies, Carlsbad, CA) (dilution 1:200) at 4°C for 6 h. Nuclei 







2.2.7 Laser scanning confocal and light microscopy 
Images of neurospheres were taken every 24 h during 3 days using bright field and phase 
contrast in a CKX41 Olympus inverted microscope. All images were collected using an 
AmScope (10MP) camera. Confocal microscopy was performed using a Nikon A1R-MP 
confocal microscope with objectives Apo 40X (1.25 NA) and Plan Fluor 40X-oil (1.3 
NA). Confocal reflectance microscopy was performed to analyze the structure of the 
collagen-hyaluronan matrices in their hydrated state. The images were obtained from 
three independent samples for each matrix at random positions using the objective Plan 
Fluor 20X (0.75 NA) in reflectance mode.  
 
2.2.8 Analysis of morphology and migration 
Bright field and phase contrast images were analyzed using the software ImageJ (NIH, 
Bethesda, MD). Migration distance was quantified as the distance from the initial 
perimeter of the neurosphere to the edge of the most external protrusion or migratory 
cell.47,62 Average migration velocity was calculated by dividing the distance recorded by 
the time interval chosen (24, 48 or 72 h). 
 
2.2.9 Statistical analysis 
Quantitative data were compared by t-test (α=0.05), Mann-Whitney or ANOVA using the 







2.3 Results  
 
2.3.1 GBAM1 presents stem-like characteristics 
 
GBAM1 human patient-derived cells were previously sorted and isolated for CD133+ 
expression. To corroborate that the cells met all criteria to be considered a stem-like 
population9 we tested the formation of neurospheres during liquid standard culture, 
expression of the stem-like markers and ability to differentiate into glial cells. GBAM1 
cultured in liquid platform formed non-adherent neurospheres in all stages of culture (Fig 
2.1 A).  
 
Figure 2.1 A. GBAM1 form non-adherent neurospheres in liquid culture. Bars 200 µm. B 
GBAM1 differentiate after 15 days of culture in differentiation medium. Bars 100 µm. 
 
Immunofluorescence staining showed that neurospheres expressed the stem markers 
Sox2, Notch, and CD133+ and did not express the standard marker for reactive astrocytes 





stem-markers, but expressed GFAP (Fig 2.2 B). Evaluation of the ability of GBAM1 to 
differentiate into glial cells after deprivation of growth factors and addition of FBS, 
resulted in visible morphological change, and gaining of adherence, all characteristics of 
differentiated brain cells in liquid culture (Fig 2.1 B).  
 
 
Figure 2.2 A. GBAM1 neurospheres (passages 17-23) exhibit markers of GBM cancer 
stem-like cells (CD133, Sox2 and Nestin) after 5 days of liquid culture. GFAP marker for 
differentiated astrocytes is not expressed. B. Human primary astrocytes do not express 






2.3.2 Modulation of GSC migration by Matrigel characteristics 
 
Invasion of cancer cells has been traditionally studied in Matrigel matrices due to its 
similar composition to the basement membrane (BM), an in vivo type of ECM used by 
cancer cells for invasion.55,63 To investigate the migration of GSCs in matrices of similar 
composition to BM, neurospheres were seeded in Matrigel (100%), Matrigel (75%)-
DMEM/F12 (25% v/v) and Matrigel (50%)-DMEM/F12 (50% v/v) to monitor migration.  
During the first 24h neurospheres developed thin pseudopodia-like extensions that were 
more abundant and larger in Matrigel 50% compared to other Matrigel matrices. 
Subsequently, the extensions exhibited in Matrigel 75% and 100% disappeared, and cells 
continued expanding as a functional aggregate with spherical morphology resembling 
multicellular migration by expansive growth (Fig. 2.3).(33) Contrastingly, the initial 
pseudopodia developed in Matrigel 50% extensions were gradually replaced by large and 






Figure 2.3 GSC neurospheres present different migration characteristics when seeded 
within Matrigel matrices of different concentration. Neurospheres exhibit migration by 
expansive growth when cultured in 3D matrices of Matrigel 100% and 75%, while in 
Matrigel 50% exhibit multicellular strand migration due to low stiffness of the matrix 
(semi-3D substrate). Bars 100 µm. Migration was determined as the distance from the 
initial perimeter of the neurosphere to the edge of the most external strand or migratory 
cell. 
 
3D reconstruction from confocal microscopy images of neurospheres cultured in Matrigel 
50% showed that the tips of the migratory strands were located on the same focal plane 
(Fig 2.4 A) suggesting that in contrast to the other 3D matrices, Matrigel 50% allowed 
the generation of focal contacts with the plate surface generating a semi-3D (or 2.5D) 
substrate.64 It is possible at this Matrigel concentration, the material shear storage 
modulus became low enough (Table 2.1) for the neurospheres to settle and interact with 






Table 2.1 Viscoelastic properties of the different matrices used for 3D migration studies 
of GSCs (n=3), mean ± SEM.  
 
Matrix Shear storage modulus G' (Pa) Matrix 
Shear storage  
modulus G' (Pa) 
Matrigel 100% 56.5 ± 3.1 BD-Col 3 mg/ml 24.5 ± 0.3 
Matrigel 75% 35.6 ± 0.8 BD-Col 1.5 mg/ml 6.5 ± 1.9 
Matrigel 50% 17.9 ± 0.3 Atelocollagen 4 mg/ml 39 ± 2.1 
Oligomer 3 mg/ml 885 ± 92.3 Atelocollagen 2 mg/ml 4 ± 1.3 
Oligomer 2 mg/ml 397 ± 32.7 HA:2 mg/ml-Col:2 mg/ml  126.2 ± 14.6 
Oligomer 1.5 
mg/ml 225 ± 14.1 
HA:5 mg/ml -Col:2 
mg/ml 107.9 ± 19.6 
Oligomer 1 mg/ml 90 ± 5.2 
HA:10 mg/ml -Col:2 
mg/ml 36.1 ± 0.6 
Note: Stiffness of normal brain tissue ranges between 260-500 Pa.65 Although 




To corroborate that multiple cells in contact formed the extensions we performed 
immunostaining to detect expression of N-cadherin. The results suggest maintenance of 
cell-cell contacts in both, the cells forming the neurosphere and the cells migrating as 
multicellular extensions (Fig 2.4 B). In comparison, GSCs in 3D Matrigel expanded into 
significantly smaller distances and with significantly slower velocities compared to the 








Figure 2.4 A. Z-reconstruction of GSCs migrating in Matrigel 50% after 24 h shows that 
collective migrating extensions are located in the same focal plane. B. GSCs cultured in 
Matrigel 50% develop contacts with rigid surfaces of the plate (semi-3D substrate) giving 
onset to wide, stable and long protrusions comprised of one or more cells with intact and 
stable cell-cell contacts. Neurospheres after 72h of culture were fixed and stained with 
Hoechst 33342 and N-cadherin-Alexa 488. Staining for nuclei was incomplete due to the 
high density of the neurosphere. Bars 25 µm 
 
2.3.3 Type-I collagen matrices support single cell migration of GSCs regardless of 
collagen concentration or formulation 
 
 
Fibrillar collagens are ubiquitous components of the ECM in the majority of tissues and 
organs and have been demonstrated to be present within glioma tissues and its 
surrounding ECM during tumor progression.16 To further explore the morphology and 
migration characteristic of GSCs, type-I collagen matrices with diverse characteristics 
were generated using type-I oligomers (Oli) isolated via acid-solubilization of pig skin, 
type-I atelocollagen from pepsin-treated pig skin (Atelo), and BD-Biosciences type-I 





single cell migration (Fig 2.5) consistent with the migration mode presented by other 
glioma cells in commercial collagen.47,62 Different concentration of collagen, absence of 
telopeptides (atelocollagen), or collagen source (commercial rat tail or pig skin) did not 
modulate the migration mode exhibited. Neurospheres cultured in collagen developed 
thin pseudopodia–like extensions with subsequent detachment of single cells from the 
neurosphere. Migration occurred in all directions with cells presenting a spindle-shape 







Figure 2.5 GSC neurospheres embedded in multiple types of collagen type-I matrices 
present single cell migration mode. Bars 100 µm. 
 
2.3.4 Collagen formulation and concentration influence migration distance and velocity 
of GSCs 
 
Parameters such as collagen source, isolation method, and polymerization reaction 
conditions dictate the mechanical and physical properties of self-assembled collagen 

















































studies have explored glioma migration in collagen, only standard commercial 
monomeric collagen was used to generate 3D matrices.46,47,62 Unlike conventional 
monomer matrices, which represent entanglements of long fibrils, oligomers induce 
interfibril associations to yield branched fibril networks. Here, collagen matrices were 
prepared at concentrations ranging from 1-4 mg/ml, and GSCs migration distance and 
velocity were measured as a function of concentration, formulation and matrix stiffness.  
 
Variation of collagen concentration affected the migration velocity of GSCs (Fig 2.6). 
The relationship between concentration and velocity was specific for each of the collagen 
formulations. Atelocollagen matrices, prepared from collagen molecules in which 
telopeptide regions have been enzymatically eliminated showed short migration distances 
and low matrix stiffness values (Fig 2.7 Table 2.1) along with low velocities that slightly 
increased with concentration (Fig 2.6). BD-collagen matrices also exhibited low stiffness 
and induced slightly higher although non-statistically different levels of invasion 
compared to atelocollagen. However, the velocity decreased moderately as the collagen 
concentration increased (Fig 2.6). In contrast to other formulations, oligomer presented 
the highest stiffness at the same fibril density (Fig 2.7 Table 2.1) and a broad range of 





Figure 2.6  BD1.5 (BD-Col 1.5 mg/ml), Oli (oligomer), Ate (atelocollagen). The highest 
velocity was reached in Oligomer 1.5 mg/ml and Oligomer 2 mg/ml, 2 mg/ml. Maximum 
velocity was reached during the first 24 h of culture and decreased subsequently. Values 
marked as * are statistically different from ** p-value<0.05, † are statistically different 
from †† p-value<0.05. n=9 (Oligomer), n>4 (BD-Col and atelocollagen), error bars 
indicate ± SEM 
 
The velocity and distance increased with oligomer concentration until reaching a 
maximum in 2 mg/ml matrices, subsequently, velocity and distance decreased for 
matrices of higher concentration (3 mg/ml) (Fig 2.6). Interestingly, matrices such as BD-
Col and Ate that represented the low-end of the matrix stiffness spectrum (4-39 Pa) 
supported low migration distances and velocities similar to those obtained in matrices as 
Oli-3 that represented the highest matrix stiffness (885 Pa) evaluated and exhibit higher 
cell-matrix contacts but reduced porosity. Analysis of oligomer matrices encompassing a 
wider range of stiffness values (90–885 Pa) suggested an optimum range where the 
maximum migration is reached (Fig 2.7). GSCs cultured within matrices Oli-1.5 and Oli-








Figure 2.7 Optimal migration velocity of GSCs in collagen-I occurs at stiffness levels in 
the range found in normal brain (represented in green section).65 Values marked as * are 
statistically different from **, † are statistically different from ††, p-value<0.05. 
Oligomer matrices with G’ of 225 Pa (Oligomer 1.5 mg/ml) and 397 Pa (Oligomer 2.0 
mg/ml) supported the greatest migration distance and velocity compared to other collagen 
matrices. Error bars indicate ± SEM 
 
2.3.5 Presence of hyaluronan in composite matrices reduces GSC migration 
 
To recreate some essential features of glioma ECM composition and study the migratory 
behavior of GSCs, composite matrices of hyaluronan (HA) and type-I collagen (Col) 
were generated with 0, 2, 5, and 10 mg/ml of HA and a constant oligomer concentration 
of 2 mg/ml. GSC neurospheres cultured in Col-HA matrices exhibited early pseudopodia 
extension followed by single cell migration similar to what was observed in collagen-
only matrices. Nevertheless, increasing hyaluronan concentration proportionally reduced 
migration as well as the frequency of cell detachment from the neurospheres (Fig 2.8 
A,B). Cells cultured in Oligomer 2 mg/ml exhibited the greatest migration distance, while 




migration compared to only oligomer matrices. The most drastic reduction was observed 
in HA:10-Col:2 mg/ml where very few cells detached from the neurosphere and migrated 
considerable short distances. Cells that left the neurosphere were able to increase the 
migration velocity over time different to what was observed for the other matrices (Fig 
2.8 C). Additionally, presence of HA induced morphological changes of the migratory 
cells. Cells switched from an elongated morphology observed in the only-oligomer and 
HA:2-Col:2 mg/ml matrices, to a mixed population of elongated and rounded cells in 











Figure 2.8 A. GSCs present single cell migration in composite Oligomer-hyaluronan 
matrices similar to only-oligomer matrices. Increasing concentration of hyaluronan 
decreases the number of migrating cells and alters the morphology of the migratory cells 
from elongated to spherical shape. White arrows point out elongated migrating cells, 
black arrows point out rounded migrating cells. Bars 100 µm B. Distance of migration is 
reduced with increasing presence of HA. All matrices present statistically different 
distance at all time points excepting HA:2-Col:2 and HA:5-Col:2 mg/ml C. Velocity 
decreased with time as observed with other matrix types, except HA:10-Col:2 mg/ml 
matrix where the velocity increased with time. Values marked as * are statistically 
different from ** p-value<0.05, † are statistically different from †† p-value<0.05, #, ## 
and ### are statistically different p-value<0.05. n=9, error bars indicate ± SEM. 
 
2.3.6 Addition of hyaluronan modulates fibril microstructure and mechanical properties 
of oligomer matrices 
 
To further analyze how the incorporation of hyaluronan altered the mechanical properties 
of the matrices and the migratory behavior of GSCs, we performed viscoelastic shear 
tests of the composite matrices. Increasing HA concentration reduced the storage and loss 




greater values of the storage modulus compared to the loss modulus, indicate that the 
matrix dynamic response is mainly controlled by the elastic (solid) phase. Structural 
changes of the matrix caused by HA were examined by confocal reflectance microscopy 
(CRM) and suggest that hyaluronan incorporation does not affect fibril density, as was 
expected for matrices of the same collagen concentration, but disrupts the formation of 
interfibril associations reducing the fibril branching (Fig 2.8). Since collagen fibril 
branching is correlated with matrix stiffness,66 the reduction of fibril associations caused 
by HA might have contributed to stiffness reduction. 
 
Table 2.2 Viscoelastic properties of the composite matrices of oligomer collagen and 
hyaluronan (n=3), mean ± SEM. HA: hyaluronan. 
 
Matrix Viscoelastic Properties 
  G' (Pa) G'' (Pa) δ (degrees)  
HA:2-Col:2 mg/ml  126.2 ± 14.6 15.8 ± 0.4 7.2 ± 0.1 
HA:5-Col:2 mg/ml 107.9 ± 19.6 13.4 ± 2.2 7.1 ± 0.1 
HA:10-Col:2 mg/ml 36.1 ± 0.6 3.7 ± 0.1 5.9 ± 0.0 
 
 
Figure 2.9 Confocal reflectance microscopy of oligomer matrices with varied 
concentration of hyaluronan. Hyaluronan presence altered the collagen interfibril 





2.3.7 Glioblastoma stem cells (GSCs) exhibit multiple migration modes 
 
We next asked what would be the overall migratory response of GSCs in a 3D in vitro 
microenvironment that mimics the composition and topography of the glioma 
environment in a single 3D construct. To address this question we cultured GSC 
neurospheres in a composite matrix of HA:10-Col:2 mg/ml with embedded Matrigel 
coated microfibers to imitate the structural tracts formed by the blood vessels thereby 
providing the cells diverse migratory paths. We observed that neurospheres located close 
to the fibers migrated towards the fiber and developed strand collective migration using 
the topographical cues as physical support (Fig 2.10 A). Cells migrating along the rods 
maintained cell-cell contacts during movement as was identified by the expression of N-
cadherin and did not separate from the neurospheres, whereas cells facing the collagen-
hyaluronan matrix directly (no rods nearby) detached from the neurosphere and exhibited 
single cell migration as was observed previously in only-collagen and collagen-
hyaluronan matrices.  
The velocity and maximum distance for collective migration along the rods (Fig 2.10 B, 
C) were comparable with the values obtained for single cell migration in oligomer 2 
mg/ml matrices and are greater than the values obtained for migration in oligomer-
hyaluronan matrices. The results indicate that multicellular strand migration exhibited 
during durotaxis, such as along the structural cues in composite matrices and in the semi-
3D (Matrigel 50%) matrix, is the most productive and fastest migration mode as it favors 







Figure 2.10 A. GSC neurospheres exhibited multiple migration modes in composite 
matrix as single cell migration mode across the 3D matrix and collective strand migration 
along the topographical cues present in the matrix. Immunofluorescence was used to 
detect N-cadherin. N-cadherin appears in green and nuclei in blue. Staining for nuclei 
was incomplete due to the density of the neurosphere. Bars 100 µm. B. Distance of 
migration along the rods increases with time and presents values comparable to those 
obtained during migration in Matrigel 50%. N=4, error bars indicate ± SEM. C. Velocity 
of migration along the rods slowly decreases with time presenting values comparable 
with other types of matrices such as Oligomer 2 mg/ml, n=4, error bars indicate ± SEM. 
D. Comparison of GSCs maximum distance of migration in different types of matrices at 
72 hours, n=9. E. Comparison of GSCs velocity of migration in different types of 







Migration of glioblastoma stem cells (GSCs) has been linked to post-operative tumor 
recurrence. Nevertheless, the migratory characteristics of this cell population in diverse 
types of extracellular matrices, has not been previously studied in detail. Here, we used 
multiple 3D formats commonly used for tumor invasion studies such as Matrigel and 
type-I collagen as well as a novel composite in vitro model that mimics the ECM 
composition, physical properties, and topography of glioma microenvironment. Our 
results indicate that GSCs exhibit varied velocities and migration modes such as 
collective migration, expansive growth, single-cell migration and combined collective-
single migration as a function of the composition and physical characteristics of the 3D 
microenvironment. 
In 3D matrices of Matrigel, the neurospheres adopted a rounded morphology resembling 
expansive growth. Such morphology can be associated with the structural characteristics 
of the matrix. Matrigel presents different crosslinking patterns as well as larger pore sizes 
than native BM,55,67 and does not confine or resist neurosphere expansion. As a 
consequence, cells tend to exhibit characteristics related to proteolysis-independent 
migration such as amoeboid morphology for single cells68 or expansive growth,25 
consistent with the morphology observed in Matrigel 75% and 100%. Our results also 
suggest that reduction of matrix stiffness as in Matrigel 50% generates a semi-3D (or 
2.5D) substrate where close contact between the neurospheres and the rigid surface of the 
culture plate allows the formation of focal contacts and stable multicellular strands 




The drastic change of GSCs morphology to strictly elongated, mesenchymal-like, single 
migration in type-I collagen corroborates the relevance of the ECM properties on the 
regulation of cancer cell migration. Fibrillar collagen although non present in normal 
brain ECM, has been found in glioma tissues, surrounding ECM,15 and as a component of 
the GSCs niche,(16) suggesting that glioma cells deposit it to support tumor migration. 
While previous studies have explored the migration of glioma cells in collagen matrices 
by using established cell lines and commercial collagen,46,47,62 we focused on studying 
the invasiveness of GSCs due to their role in tumor migration and regrowth. Additionally, 
we generated matrices with oligomer collagen that as recent reports showed, offers a 
number of advantages over conventional monomeric collagens, including hierarchical 
collagen fibril assembly that recapitulates that observed in vivo, presence of tissue-
specific intermolecular crosslinks, short polymerization time, and customization over a 
broad range of relevant physicochemical features.61 GSC neurospheres exhibited single 
cell detachment and mesenchymal migration in all the types of collagen matrices studied, 
consistent with the migration mode presented by other glioma cells lines in 3D-collagen 
matrices.47,62 The velocity and distance of migration were modulated by the concentration 
of the collagen as was expected due to changes in the fibril density and pore size of the 
matrix.54,61 In atelocollagen matrices where no crosslinks are present, increasing 
concentration resulted in higher migration due to higher generation of cell-matrix 
contacts and proteolysis-independent migration. In covalently cross-linked matrices such 
as BD-collagen and oligomer, increasing collagen concentration reduces the pore size and 
the available space for cell movement; hence, migration relies on the ability of the cell to 




appropriate size to move through the pores.69 Similarly, reduction of the collagen 
concentration and consequent increase of the pore size can also reduce migration due to 
the lack of structural support for the development of cell-matrix contacts and generation 
of traction force to propel movement. These differences in migration due collagen matrix 
concentration are similar to observations by other authors62 and support the existence of 
an optimum collagen concentration range where the fibril density and pore size support 
the maximum cell migration.70–72 
 
Hyaluronan enrichment of the ECM and overexpression of CD44 receptors have been 
associated with glioma invasion of brain parenchyma.73–75 Interestingly, when increasing 
quantities of hyaluronan were incorporated to collagen matrices to resemble glioma 
microenvironment, the number of migratory cells and migration distance were reduced. 
Also, the cell morphology shifted to a more-rounded appearance. Previous studies of 
collagen-hyaluronan 3D matrices43,45,46 have related increasing HA concentrations with 
matrix stiffness and subsequent reduction of cell migration with adoption of rounded 
morphology. Similarly, in PEG-HA matrices, increased stiffness has derived in changes 
of cell morphology.76 Nevertheless, our results showed that incorporation of non-
crosslinking hyaluronan decreases matrix stiffness (Table S1) but also induces adoption 
of cell-rounded morphology. As other studies of acid-solubilized collagen matrices have 
shown, HA incorporation increases interstitial fluid movement resistance without 
affecting fibril density.(45) Consistently, Col-HA matrices presented a similar fibril 
density upon HA addition, however the interfibrilar associations were disrupted. 




caused by HA during matrix polymerization,66 and the adoption of cell rounded 
appearance is mainly due to increased resistance of the interstitial fluid caused by 
hyaluronan hydration that opposes an additional barrier for cell deformation and 
movement. 
 
It is accepted that GBM presents a rapid infiltration pattern with preference for 
myelinated axons and blood vessels.(14) Recently it was shown using in vivo xenograft 
models that GBM cells present directional and efficient migration (greater net distance 
and velocity) along blood vessels while migration through the parenchyma occurs by 
expression of multiple pseudopodia with constant changes in direction.78 Certain GBM 
cell lines also presented a chain-like morphology when extending from the tumor to the 
blood vessels.79 In line with such findings, our results, obtained using an in vitro 
composite matrix, suggest that GSCs detect the asymmetric rigidity gradient presented in 
the environment and develop different migration modes according to the mechanical 
properties of the structures to invade. Migration across collagen-hyaluronan matrix, 
which poses a low-stiffness environment triggers cell detachment and single cell 
migration with constant changes of direction; however, when rigid structures (as the 
microrods) are presented to the neurospheres, the cells develop collective strand 
migration along the directional tracts. Such migration mode by multicellular strands was 
present along rods regardless of the percentage of Matrigel coverage on the rod surface. 
Hence, we suggest that the rigidity of the topographical clue coupled with the proximity 




migration, and that this type of collective migration is likely to be present not only along 




In this study we describe a new composite tunable matrix that resembles important 
features of glioma microenvironment as ECM composition, mechanical properties and 
preexisting structural cues. This model can be used to dissect and increase our 
mechanistic understanding of the migratory behavior of GSCs in 3D environments. 
Furthermore, we analyzed multiple matrices of varied mechanical properties using 
Matrigel and diverse types of fibrillar collagen, to assess how the migratory 
characteristics of GSCs are affected by the physical properties of the matrix. Our results 
indicate that GSC neurospheres are able to exhibit multiple velocities and migration 
modes such as collective migration (expansive growth and strand)82 and single cell 
migration (mesenchymal) as a function of the mechanical and compositional properties of 
the matrices. In a composite collagen-hyaluronan matrix, the migration of GSCs was 
reduced by the presence of hyaluronan; nonetheless, cells adopted a productive and fast 
migration as a collective strand by using the preexisting topographical cues presented as 
migratory paths. Taken together the results suggest that GSCs migration is not limited to 
a unique migration mode as is usually observed in in vitro studies, but are able to exhibit 
concomitantly multiple migration modes (collective and single) as a response to the 
heterogeneity of the environment. The recreation of additional characteristics of cancer 




controllable 3D-models is a powerful tool to study cancer development and progression. 
Additional efforts in this area will contribute to the elucidation of fundamental 
mechanisms such as how cell sensing of the microenvironment composition and 























CHAPTER 3. INFLUENCE OF THE EXTRACELLULAR MATRIX AND STROMAL 
CELLS ON GLIOBLASTOMA DRUG RESPONSE  
3.1 Introduction 
 
Recognition of the tumor microenvironment as a biological regulator of GBM 
progression is critical not only to elucidate the biological mechanisms involved in tumor 
development and progression but also in the early stages of the development of drug 
treatments that effectively target the cancer cells and their supportive niche. Presence of 
the tumor microenvironment has been correlated with poor response of cancer cells to 
chemo- and radiotherapy as well as to inhibition of immune surveillance.51,83,84 An 
appropriate example of the importance of the understanding the dynamic relationship 
tumor-microenvironment during drug development has been the development of anti 
cancer drugs such as Bevacizumab that target the interaction with tumor- 
microenvironment. Bevacizumab, an antibody that inhibits the vascular endothelial 
growth factor-A (VEGF-A) was approved for GBM treatment to directly inhibiting tumor 
angiogenesis.85 Despite the overall dismal improvement that Bevacizumab has have on 
GBM patients,86 recognition of the synergistic relationship tumor-microenvironment as a 
potential drug target has been a fundamental step in the development of more effective 




Given the importance of tumor microenvironment during GBM drug response, a close 
representation of its multiple components during early stages of drug development is 
fundamental for the development of translational therapies. The use of in vitro platforms 
that represent more closely the in vivo settings of the tumor microenvironment has 
multiple advantages such as presence of cell-ECM interactions and existence of nutrient 
and oxygen gradients.83,87 However the majority of these approaches are only focused on 
the recapitulation of the 3-dimensionality of the tumor and presence of ECM and very 
few have also considered the effect of stromal cells as components of the tumor 
microenvironment.  
3D scaffold-based co-culture models are powerful tools to represent the tumor 
microenvironment since can incorporate the ECM, stromal and tumor cells and allow 
controlled analysis of the role of intercellular signaling on tumor behavior. Despite the 
great advantages that these models offer for initial drug screening of potential GBM 
treatments, a comprehensive 3D model of GBM microenvironment that accounts for 
ECM and tumor cell heterogeneity has not been yet developed. In this work we use a 3D 
in vitro tissue model that recapitulates the physical characteristics of GBM ECM with 
incorporated stromal cells as astrocytes and endothelial colony forming cells (ECFCs) to 
determine the role of both, extracellular matrix and stromal cells presence on the viability 
of GBM after drug treatment. To achieve a more comprehensive conclusion on the effect 
of microenvironment on GBM survival, we used multiple patient derived GBM cell lines, 
including stem-like and non-stem GBM cells. Furthermore, different drug treatments 




Temozolomide is the standard chemotherapeutic agent for GBM treatment and acts by 
damaging (through methylation) the DNA and inducing cell death. Nutlin-3a acts as a 
MDM2 inhibitor, a negative regulator of p53 tumor suppressor and has shown very 
promising results for treatment of multiple cancers types, especially in combination with 
other treatments.88,89 Lastly, we used a newly developed small molecule inhibitor of 
signal transduction and activator of activation STAT3 (SH-4-54), this drug acts by 
inhibiting the phosphorylation of STAT3 required for activation of genes involved in 
cancer associated processes as metastasis, proliferation and survival and has been proved 
to effectively reduce survival of brain tumor initiating cells (also called tumor stem-like 
cells).90 
3.2 Experimental Methods  
 
3.2.1 Cell culture in liquid substrates 
GBM human–derived cell lines GBM10 and GBM43 were originally obtained from Dr. 
Jann Sarkaria (Mayo Clinic, Rochester, MN) and have been described elsewhere.91 
MHBT32 is a low passage primary patient line kindly donated by the Dr. Karen Pollok 
and Dr. Aaron Cohen at Indiana University and the Methodist Hospital of Indianapolis. 
All cell lines were maintained in high-glucose DMEM (Life Technologies, Carlsbad, CA) 
supplemented with 10% FBS. Cell line U87MG was maintained in IMDM (Life 
Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM human cell line 
GBAM1 (CD133+ >98% from passages 22-25) provided by Dr. Phillip Tofilon and the 




vitamin A (Life Technologies, Carlsbad, CA) and with growth factors EGF, bFGF (50 
ng/ml each, Peprotech, Rocky hill, NJ). Human primary astrocytes from ScienCell 
(Carlsbad, CA) were maintained according to vendor specifications. Endothelial 
umbilical cord blood ECFCs from EndGenitor Technologies (Indianapolis, IN) were 
cultured in collagen type-I coated T-75 flasks in EGM-2 medium (Lonza, Walkersville, 
MD). All cell lines were cultured at 37°C in an atmosphere of 5% CO2, fed with complete 
media every other day and passaged at 70-80% confluence. 
 
Table 3.1 Properties of human-derived GBM cell lines  
 




p53 status p16 deletion 
GBAM1(CD133+) - - - - 
GBM10 No wt wt Yes 
GBM43 No wt 170 Phe>Cys Yes 
MHBT32 - - - - 
 
3.2.2 Cell culture in the 3D brain-like matrix 
3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen 
(GeniPhys, Zionsville, IN) at concentration 2 mg/ml as described by Whittington (2013). 
Sodium hyaluronate (MW 351-600) KDa (Lifecore Biomedical, Chaska, MN) was 
dissolved in 10X PBS during collagen neutralization to attain a final concentration of 10 
mg/ml of hyaluronan. GBM cells were suspended at the desired density in the 3D matrix 
prior polymerization at 37°C for 30 minutes. Complete media was added to the top of the 





3.2.3 Drug treatments 
GBM cells were cultured for 24 h (in liquid medium or within the 3D Col-HA matrix) in 
a 96-well plate at 5000 cells/well with 100 µl of complete media prior addition of one-
time dosage of the drug treatments. Co-culture of GBM with with stromal cells was done 
at a ratio 1:1 or 1:1:1. The drugs Nutlin-3a, anti-STAT3 inhibitor SH-4-54 and 
Temozolomide (TMZ) (Sigma-Aldrich, St. Louis, MO) were dissolved in DMSO and 
added to a total of 200 µl of medium per well. Controls were treated with DMSO. 
Combination drug treatments of SH-4-54 at fixed concentration of 5 µM with varied 
concentration of Nutlin-3a (0 - 50 µM) were performed in liquid and 3D culture for 
GBAM1 and GBM10. Dual combination of Nutlin-3a (25 µM) and SH-4-54 (5 µM) or 
triple combination of Nutlin-3a (25 µM)+ SH-4-54 (5 µM)+TMZ (1050 or 750 µM) were 
tested both in liquid and 3D culture in GBAM1 and GBM10 cell lines. 
 
3.2.4 Assessment of cell viability 
Viability of GBM cells cultured as 2D monolayer or in 3D Col-HA matrix was assessed 
72h or 120h after drug treatment using Alamar blue assay (ThermoFisher Scientific, 
Waltham, MA). Alamar blue solution was added to each well to reach 10%v/v; cells were 
incubated with the reagent for 3h at 37°C and fluorescence was measured (560 nm 
excitation - 590 nm emission).  Readings were normalized to DMSO control to calculate 
viability percentages. 
For assays involving co-culture of GBM with astrocytes and ECFCs the GBM cells were 
marked with CellTracker™ Green CMFDA dye (ThermoFisher Scientific, Waltham, MA) 




by treating the samples for 10 min with viability dye eFluor 660 (eBiosciences) 72h after 
drug treatment. Total GBM cells were detected by Celltracker green and dead GBM cells 
by colocalization of both dyes using ImageJ software. 
 
3.2.5 Statistical analysis 
All measurements are expressed as mean SD unless otherwise stated. Comparisons 
between treatments were made using two samples t-test or one-way analysis of variance 
(ANOVA) with Tukey-Kramer mean comparison.  Analysis of effect of drug treatment 
and presence of other cells on GBM migration was made using two-way analysis of 
variance with Tukey-Kramer mean comparison. Statistical significance was evaluated at 
α = 0.05. 
 
3.3 Results  
 
3.3.1 Effect of temozolomide (TMZ) treatment on GBM cell viability in 2D liquid 
culture 
 
GBM cell lines were treated with varied concentration of temozolomide (TMZ) as a one-
time dosage, and cell viability was evaluated 5 days after treatment using Alamar blue 
assay. The concentration range of treatment was chosen based on previous studies by 
collaborators for IC50 determination (data not shown). We observed that all the cell lines 
exhibited a weak response to low TMZ concentrations (Fig 3.1). TMZ IC50 for cell lines 




values were much higher than previously determined by our collaborators using a 
methylene blue proliferation assay (Table 3.2).  TMZ IC50 for MHBT32 was reported at 
5.8 µM (Table 3.2), however in our hands, this cell line showed low response to treatment 




Figure 3.1 Patient derived GBM cell lines exhibit weak response to TMZ treatment in 2D 
liquid culture. MHBT32 cell line was resistant to increasing concentrations of TMZ. Data 
presented as Mean ± SD (n=>3) 
 
Table 3.2 Comparison of GBM TMZ IC50 in 2D liquid culture. Relative IC50 calculated 









GBAM1 Unknown 735 110 
GBM10 923 1383 40 
GBM43 263 800 26 
MHBT32 5.8 > 200 17 















































































3.3.2 Effect of MDM2 and STAT3 inhibitors on GBM cell viability 
 
Given the poor response to temozolomide exhibited by all GBM cell lines studied, we 
tested the effect on viability of the MDM2 inhibitor Nutlin-3a alone and in combination 
with SH-4-54, a newly synthesized STAT3 inhibitor. Cell viability was evaluated 72h 
after drug treatment with concentrations of Nutlin-3a ranging from 5 to 50 µM as single 
treatment or combined with a 5 µM of SH-4-54. Treatment with Nutlin-3a decreased 
viability in all cell lines (Fig 3.2). Concentrations of Nutlin-3a as low as 5 µM reduced 
viability of GBAM1, GBM10 and U87MG to 82%, 75% and 35% respectively. Yet, 
increasing Nutlin-3a concentration to 25 µM did not affect viability when compared to 5 
µM. Further increase in Nutlin-3a concentration to 50 µM caused a drastic decrease in 
GBM viability, especially in GBM43 and U87MG than presented only 20% viability 
after treatment. Stem-like GBAM1 presented less sensitivity to Nutlin-3a than the other 
cell lines reaching 65% viability at maximum concentration studied (50 µM). Treatment 
with SH-4-54 reduced viability of stem-like GBAM1 when combined with 5 and 50 µM 
of Nutlin-3a, however combination treatment had no effect on GBM10, GBM43 or 





Figure 3.2  Nutlin-3a treatment decreases the viability of all GBM cell lines studied. 
Combination of Nutlin-3a with SH-4-54 further decreases viability in stem-like GBM cell 
line GBAM1 but does not potentiate the effect of Nutlin-3a in non-stem GBM cells. * 
Represents statistical difference at α=0.05. 
 
 
3.3.3 Dimensionality influences GBM response to drug treatment  
 
Since the cell lines GBM10 and stem-like GBAM1 presented similar responses to TMZ 
and Nutlin-3a but had very different responses to anti-STAT3 treatment, we evaluated the 
drug response of cells cultured both, in standard 2D liquid monolayer and in a brain-like 
3D model of collagen-hyaluronan. GBM viability after drug treatment tends to be higher 
for cells cultured in the 3D model compared to 2D liquid, although in certain cases, for 
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instance when the drug effect is very low (SH-4-54 on GBM10) the difference in survival 
between 3D and 2D culture is not significant. Interestingly, GBM10 treatment with 
Nutlin-3a showed a very different tendency compared to other drugs and cell lines, in this 
particular case, viability during 3D culture was lower than in 2D liquid. In general, in 
contrast to 2D liquid culture, viability in 3D culture after treatment was greater than 75% 
despite the drug or concentration used, which likely suggests that dimensionality and 




Figure 3.3 Differential effects on drugs on GBAM1 and GBM10. The presence of a 3D 
ECM reduces the cytotoxic effect of all drugs tested in GBAM1. However presence of 
the ECM has a differential effect on GBM10 viability. * Represents statistical difference 
at α=0.05. 
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3.3.4 3D co-culture with astrocytes increases viability of GBAM1 after TMZ treatment  
 
Stromal cells present in the tumor microenvironment influence tumor progression. In the 
case of brain, astrocytes are the main non-neural cell type and comprise nearly 50% of 
total brain volume. To determine the influence of stromal cells in GBM drug response, 
we incorporated astrocytes along with GBM cells into the 3D model of collagen-
hyaluronan to evaluate GBM survival after treatment with temozolomide. Incorporation 
of astrocytes significantly increased viability of the stem-like cell line GBAM1 after 
TMZ treatment compared to GBM 3D culture without astrocytes (Fig 3.4). In contrast, 
there was only a slight increase in GBM10 viability in presence of astrocytes. Presence of 
astrocytes in the 3D model increased viability of the stem-like cell line GBAM1 from 60% 
to 120% and from 59% to 72% in GBM10 after TMZ treatment when compared to 2D 
liquid culture, showing that combined factors such as presence of the ECM and brain 
stromal cells can act synergistically to decrease GBM sensitivity to drug treatment when 






Figure 3.4 Astrocyte co-culture with GBM in 3D culture decreases the cytotoxic effect of 
temozolomide in GBAM1 compared to only-GBM 3D culture. * Represents statistical 
difference at α=0.05. 
  
3.3.5 3D co-culture with ECFC and astrocytes increases viability of GBM after drug 
treatments 
 
A hallmark of GBM is the ability to induce angiogenesis to support tumor growth. 
Vascular proliferation is a defining histological feature separating GBM from lower 
grades of astrocytoma. To address the importance of endothelial cells in the GBM 
microenvironment and therefore tumor drug response, we incorporated endothelial 
colony forming cells (ECFCs), able to form vascular networks, with astrocytes and GBM 
cells into the 3D model of GBM ECM.  The multicellular 3D model was then treated 
with the STAT3 inhibitor SH-4-54, combination of Nutlin-3a (25 µM) – SH-4-54 (5 µM) 
and triple combination of Nutlin-3a (25 µM) – SH-4-54 (5 µM) - TMZ (750 µM for 




























GBM survival. Presence of astrocytes and ECFCs increased GBAM1 survival to nearly 
100% survival after treatment with SH-4-54 compared with 38% in 2D liquid culture, and 
80% in 3D culture. GBAM1 viability after dual or triple drug combination was higher in 
co-culture with ECFCs and astrocytes compared to liquid culture but not significantly 
different than in 3D culture without stromal cells. Co-culture of astrocytes and ECFCs in 
the 3D GBM10 cultures increased survival following triple treatment from 35% in liquid 
culture and 25% in 3D culture without stromal cells to 75% in 3D co-culture.  
 
Interestingly, GBM cells cultured in the 3D model with ECFCs and astrocytes exhibited 
an overall survival higher than 70% despite the drug combination that was applied. The 
effect of ECFCs and astrocytes on increasing GBM survival was especially evident after 
drug treatments that were very effective in decreasing survival in 2D culture such anti-









Figure 3.5 Presence of stromal cells in the 3D extracellular matrix drastically reduces the 
cytotoxic effect SH-4-54 STAT3 inhibitor on GBAM1 and the effect of triple drug 




Despite the widely recognized importance of the microenvironment as modulator of 
tumor behavior, current models for drug screening do not recapitulate the essential 
components of the tumor microenvironment like the presence of extracellular matrix and 
stromal cells. Previous studies have shown that cancer cells cultured in 3D environments 
can present either higher or lower sensitive to chemotherapeutic agents compared to cells 
cultured in standard 2D liquid culture.92–97 Although assessment of drug response varies 
widely depending on factors such as cancer cell line studied, 3D-culture approach, drug 
evaluated or presence of non-tumor cells, it has become clear that many characteristics of 
the microenvironment play a role in how cancer cells respond to treatment. In this study 



















































































































we evaluated the effect of the extracellular matrix and presence of brain stromal cells on 
survival of GBM after treatment with chemotherapeutic agents by using a developed 3D 
model that recapitulates the characteristics of the brain extracellular matrix and the 
presence of brain stromal cells. We observed that presence of a 3D extracellular matrix as 
well as astrocytes and ECFCs increases the survival of GBM stem-like cells after drug 
treatments compared to standard 2D liquid culture. Similarly, dimensionality and stromal 
cells affected viability of non-stem cells after treatment, however the drug effect was 
diminished or dependent on the drug tested when compared with GBM stem-like cells.  Is 
important to note that GBM10 in 2D and 3D-matrix culture was relatively resistant to all 
treatments except to triple treatment, hence the effect of extracellular matrix and stromal 
cell on GBM10 viability was only well appreciated following triple drug treatment.  
 
Evaluation of survival after drug treatment performed in 2D liquid culture showed that 
the GBM cell lines used in this study present low sensitivity to TMZ (IC50 values higher 
than 700 µM) as well as varied sensitivity to the MDM2 inhibitor Nutlin-3a and STAT3 
inhibitor SH-4-54. Nutlin-3a treatment visibly reduced the viability of non-stem GBM 
cells lines GBM10, GBM43 and U87MG but had a lesser effect on viability on the stem-
like cell line GBAM1. Sensitivity of the non-stem cell lines GBM10, GBM43 and 
U87MG to Nutlin-3a can be linked to p16 deletion in GBM10 and GBM4391 and in 
U87MG. Given the decreased functionality of p16, that functions as an MDM2 negative 
regulator, we expected higher than normal MDM2 activity in these lines. Disruption of 
the MDM2-p53 interaction by Nutlin-3a and consequent reduction of p53 degradation 




stem GBM lines studied. Effectively, Nutlin-3a reduced the viability of non-stem cell 
lines presenting mutations on p16 compared to the stem-like cell line GBAM1. Previous 
studies have recognized Nutlin-3a as an inducer of cell cycle arrest and apoptosis in wt-
p53 GBM cell lines.98 Interestingly, our results show that p53 mutants such as GBM43 
respond to Nutlin3a treatment in a similar way than wt-p53 cell lines GBM10 and 
U87MG. When Nutlin-3a was combined with the anti-STAT3 inhibitor SH-4-54 as an 
attempt to decrease viability, only stem-like cells showed reduction in viability compared 
to only Nutlin-3a treatments. Our results are in concordance with previous studies that 
shown that inhibition of STAT3 function is detrimental for the proliferation and survival 
of stem-like brain cancer cells90,99. Studies by Rahaman (2002)100 demonstrated that 
inhibition of constitutive expression of STAT3 is lethal for GBM cells. In our studies we 
did not observe such lethality, likely due to the fact that SH-4-54 inhibits phosphorylation 
and dimerization of STAT3 but does not deplete constitutively expressed STAT3.  
 
Evaluation of the role of dimensionality on GBM viability was performed in GBM10 and 
GBAM1 by comparing viability after drug treatment in liquid culture and in the 3D 
model. Presence of ECM influenced viability of the stem-like line GBAM1 regardless of 
the drug treatment applied. In all cases presence of the 3D ECM reduced the 
effectiveness of the drug and increased GBAM1 cell viability.  Previous assessment of 
the effect of dimensionality on stem-like GBM cells was done on collagen surfaces as 
semi 3D-culture platforms. Similar to our results GBM stem-like cells treated with other 
drugs like multikinase inhibitors exhibited increased viability in semi 3D platforms 




The effect of the ECM on GBM10 viability differed depending on the treatment applied. 
Presence of the 3D ECM reduced the effectiveness of TMZ but increased the effect of 
Nutlin-3a. Viability after treatment with the inhibitor SH-4-54 was very similar in 2D and 
in 3D, likely due to poor effectiveness of the compound to decrease GBM10 viability or 
due to lack of STAT3 activity. Drug response has been previously evaluated in 3D 
platforms and compared to 2D liquid response in various cancer cell lines with mixed 
outcomes regarding the effect of the ECM on increasing or decreasing sensitivity of cells 
to treatment. For instance, chemotherapeutic agents such as doxorubicin, paclitaxel and 
tamoxifen were less effective in reducing viability of breast cancer cells in 3D matrices 
compared to liquid culture.96,101 In contrast, other studies suggest that pancreatic and 
breast cancer cells cultured in 3D matrix presented increased sensitivity to drug treatment 
compared to liquid culture.94,95  
 
Different to the effect of ECM, the role of stromal cells on cancer drug response has been 
less explored. Previous attempts to assess the effect of stromal cells on cancer viability 
after drug treatment were performed in 2D liquid culture or using cancer cell spheroids. 
In both studies it was observed that the presence of stromal cells such as astrocytes and 
fibroblasts reduced effectiveness of drug treatments in GBM and breast cancer 
respectively.102,103 Still, to the best of our knowledge our 3D model for multiple co-
culture of stromal and GBM cells is the first attempt to recreate an in vitro brain tumor 
microenvironment that combines dimensionality, similar GBM ECM and stromal cells 
for testing the effectiveness of drug treatment on GBM. Similar to the results obtained by 




decreased GBM apoptosis after TMZ or vincristine treatment, we observed that a 
protective effect of astrocytes. Presence of astrocytes at a ratio 1:1 to GBM cells 
decreased sensitivity of GBAM1 to TMZ compared to both liquid culture and 3D culture 
without stromal cells. In contrast, presence of astrocytes decreased sensitivity of GBM10 
compared to liquid culture and not to the 3D culture without astrocytes.  
Dual presence of astrocytes and ECFCs reduced the effect of drug treatments that were 
very effective in liquid culture in both non-stem and stem-like GBM cell lines. 
Interestingly, we observed that presence of stromal cells in the 3D microenvironment had 
a greater effect on protecting the stem-like cell line GBAM1 against chemo-agents 
compared to the non-stem cell line GBM10. The greater effect of the microenvironment 
decreasing the sensitivity of the GBM stem-like cells to drug treatments suggest that for 
cancer stem-like cells as for normal cell progenitors the microenvironment is a complex 
and dynamic entity that regulates, supports and protects stem cell function.  
 
3.5 Summary  
 
In this study we described the effect of different components of the tumor 
microenvironment such as dimensionality and presence of stromal cells on the sensitivity 
of GBM cells to various chemotherapeutics agents. To this end we generated a 3D model 
that represents the physical, compositional characteristics of GBM ECM as well as the 
presence of stromal cells astrocytes and vasculature-forming cells. Presence of a 3D 




Nutlin-3a and STAT3 inhibitor SH-4-54 on the stem-like line GBAM1 compared to 
standard 2D liquid culture; however had a varied effect in the non-stem line GBM10. 
Incorporation of astrocytes within the 3D GBM ECM model further reduced the effect of 
TMZ on GBAM1 compared to liquid culture and GBM 3D culture without stromal cells. 
Astrocyte presence reduced sensitivity of the non-stem cell line GBM10 compared to 
liquid culture but had little effect compared to 3D culture without stromal cells, 
suggesting a possible greater protective effect of astrocytes on GBM stem-like cells. 
Combined presence of ECFCs and astrocytes into the 3D model decreased the toxicity of 
drug treatments on GBAM1 compared to liquid culture, and reduced the toxicity of 
STAT3 inhibition compared to 3D culture without stromal cells.  
Presence of stromal cells had a lesser effect on GBM10 viability. Is important to note that 
GBM10 was isolated form a recurrent GBM patient and presented overall poor response 
to drug treatment. Therefore, the effect of the stromal cells on viability was only evident 
after aggressive treatment with triple combination of TMZ - Nutlin-3a - SH-4-54. 
The recreation of an in vitro model of the tumor microenvironment offers a unique tool to 
study how different factors of the environment contribute to GBM response to chemo-
agents in order to generate therapies potentially translational to in vivo settings.  









CHAPTER 4. DIMENSIONALITY AND PRESENCE OF STROMAL CELLS 
INFLUENCE GLIOBLASTOMA MIGRATION 
4.1 Introduction  
 
Glioblastoma (GBM) is characterized by rapid infiltration across brain parenchyma. Prior 
to tumor surgical resection, cells from the primary mass leave the tumor and invade 
healthy brain tissue to form new satellite tumors that ultimately lead to patient relapse.14 
Synergistic relationships between tumor cells and the local microenvironment have been 
recognized as fundamental modulators of GBM migration and colonization strategies.104–
106 During GBM development, intercellular signaling between tumor cells and normal 
tissue constitutes one of the first steps towards the formation of a supportive 
microenvironment. Recruitment of supportive stromal cells such as vasculature forming 
cells during angiogenesis, and suppression of microglia and T-cells normal functions are 
essential for the maintenance of the tumor as a functional, self-regulating entity. 107 
Interactions of the tumor with its microenvironment and paracrine signaling with the 
supportive stroma promote GBM migration and are associated with the presence of 
similar migration patterns exhibited by the neural progenitors during early stages of the 
central nervous system (CNS) development.13 Such specific interactions are also linked to 




to other types of cancer. Further evidence of the importance of tumor-microenvironment 
interaction is the possible correlation between tumor location and patient survival. 
Patients with GBM located in the deep grey matter, which is formed mainly by the 
neurons cell body, present longer survival that patients with GBM located in the brain 
lobes, formed mainly by the axonal section of the neurons and astrocytes.108 
Brain tissue is comprised by multiple types of cells; among the most prevalent 
populations are astrocytes, microglia, neurons and the cells comprising the vascular 
network (endothelial cells and pericytes). Astrocytes are the main glial components of 
brain stroma.38 Previously, astrocytes were considered only as supporters of neural 
function and component of the brain blood barrier, only until recently their full function 
in maintenance of brain homeostasis has begun to be comprehended. Astrocytes undergo 
astrogliosis in presence of GBM cells,109 in a response that recapitulates their behavior 
after CNS injury. Reactive astrocytes increase secretion of cytokines that facilitate cell 
growth and migration as a response mechanism to control brain damage.39 It has been 
hypothesized that GBM take advantage of astrogliosis signaling to facilitate 
invasion.38,40,109,110 Among the most important signals associated with astrogliosis and 
involved in tumorigenesis is the up-regulation of matrix metalloproteinases (MMP) 
expression. MMPs are a family of proteinases able to remodel the microenvironment 
through degradation of multiple component of the extracellular matrix.111 Besides being 
important drivers of invasion (migration, extravasation and intravasation), MMPs are also 





MMP activity is regulated through many strategies, by repression of expression, presence 
of inhibitors, or secretion of an inactive isoform that will be activated by signaling cues 
of the microenvironment when required.111 The delicate balance of inhibiting MMPs is 
fundamental to avoid undesired degradation of tissue. However, during tumorigenesis the 
MMP activity is up-regulated facilitating the remodeling of the tumor microenvironment 
and the migration of cancer cells. Greater presence of MMPs in the GBM 
microenvironment has been associated to two factors, increased MMPs secretion by 
tumor cells or activation of present MMPs induced by paracrine signaling with the 
microenvironment, specifically with astrocytes. 
Similar to astrocytes, recruitment of endothelial cells by GBM is a driving factor that 
contributes to tumor migration. Cooperative interaction between endothelial cells and 
GBM induces expression of pro-angiogenic signals, atypical proliferation of endothelial 
cells and tumor neovascularization.37 Neovascularization is a hallmark of GBM and of 
the most important processes that lead to the rapid progression and invasion of the tumor. 
Due to the rapid proliferation of the cancer cells and destabilization of the vasculature, 
the tumor presents hypoxic regions that express hypoxia-inducible factor (HIF) α and β. 
As a response to hypoxia the tumor cells up-regulate the expression of vascular 
endothelial growth factor (VEGF) and attracts endothelial cells to initiate the formation 
of new vasculature. 85 New vascular networks can acts as migration routes for invasion of 
the tumor into healthy parenchyma. 
Despite the well-recognized reciprocal interaction between the tumor and its 




the main characteristics of the tumor microenvironment, namely, presence of 
extracellular matrix and stromal cells. Here, we use a previously developed 3D in vitro 
model that recapitulates the compositional and mechanical features of GBM ECM with 
incorporated astrocytes and endothelial cells to elucidate the role of different components 
of tumor microenvironment on the migration of GBM. 
4.2 Experimental Methods  
 
4.2.1 Standard liquid cell culture 
GBM human–derived cell lines GBM10, GBM43 and MHBT32 were maintained in high-
glucose DMEM (Life Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM 
human cell line GBAM1 (CD133+ >98%) was maintained in DMEM/F12 supplemented 
with B27 without vitamin A (Life Technologies, Carlsbad, CA) and with growth factors 
EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ). Human primary astrocytes from 
ScienCell (Carlsbad, CA) were maintained according to vendor specifications. 
Endothelial umbilical cord blood ECFCs from EndGenitor Technologies (Indianapolis, 
IN) were maintained in collagen type-I coated plates with EGM-2 medium (Lonza, 
Walkersville, MD) as described by Whittington (2013). All cell lines were cultured at 
37°C in an atmosphere of 5% CO2, fed with complete media every other day and 
passaged at 70-80% confluence. To obtained astrocyte conditioned medium, astrocytes 
were seeded at an initial density of 5000 cell/cm2 and cultured according to vendor 
specifications for 5 days, the media was collected centrifuged at 1000rpm for 5 min to 




4.2.2 3D Cell culture 
3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen 
(GeniPhys, Zionsville, IN) at concentration of 2 mg/ml and sodium hyaluronate (MW 
351-600) KDa (Lifecore Biomedical, Chaska, MN) was incorporated at 10 mg/ml as 
described previously in Chapter 2. Cells were suspended at the desired concentration in 
the 3D matrix prior polymerization at 37°C for 30 minutes. Complete media was added to 
the top of the matrix, and cells were cultured at 37°C in an atmosphere of 5% CO2. 
 
4.2.3 Migration on 2D surfaces 
Cells were tested for viability, stained with CellTracker™ Green CMFDA dye (Life 
Technologies, Carlsbad, CA) for visualization and plated on glass-bottom well plates at a 
density of 15000 cell/cm2 and fed with appropriate media; plates used for GBAM1 cells 
were coated with 1.5 µg/ml of Poly-L-lysine in water. For migration assays involving co-
culture with astrocytes or with astrocytes and ECFCs, astrocytes and ECFCs were 
initially plated at 15000 cell/cm2 density and cultured 24h before the addition of GBM 
cells to allow attachment to the plate surface. After GBM addition to the co-culture, cells 
were fed with media containing equal volumes of complete GBM, astrocytes and ECFC 
media and incubated during 4h for attachment of GBM cells and placed in an on-stage 







4.2.4 Migration in 3D brain-like matrix 
GBM cells were stained with CellTracker™ Green CMFDA dye (Life Technologies, 
Carlsbad, CA) and embedded at a density of 1*106 cells/ml within the collagen-
hyaluronan matrix before polymerization. For assays involving astrocytes and/or ECFCs, 
all the cells were embedded at the same time in the matrix prior polymerization and at the 
same density (1*106 cells/ml each population). Volumes of 30 µl of matrix per well were 
platted in a µ-slide angiogenesis chamber (Ibidi, Germany). After matrix polymerization, 
30 µl of media were added per well, co-cultured cells were fed with media containing 
equal volumes of GBM, astrocytes and ECFC media and maintained in incubation at 
37°C in an atmosphere of 5% CO2 for 24 h. Afterwards, cell were placed in an on-stage 
incubator to perform time-lapse confocal microscopy every 90 min during 15h.  
 
4.2.5 Time-lapse confocal imaging and migration analysis 
Cell migration was monitored by time-lapse microscopy using an Olympus FV1000 
confocal microscope equipped with 488 nm argon laser (Figure 4.1). Optimal growth cell 
conditions were maintained using on-stage incubator chamber at 37°C in an atmosphere 
of 5% CO2. Z-stacks of 200 µm were acquired using 12-15 µM steps; initial and final z 
positions were chosen to be at least 50 µm separated of the surface or the plate interface. 
Different areas (4 to 9 areas) were acquired per sample (each individual area of 0.0187 
mm2) to cover at least 60% of the total area of the well. Image stacks were projected as 
XY images for migration analysis. Trackmate plugin from FIJI was used to analyze the 
time-lapse images using LoG (Laplacian of Gaussian) detector, assuming a blob diameter 




without sub-pixel localization. LAP tracker option was chosen allowing frame to frame 
linking and closing of 15 pixels in 3D migration experiments and 25 pixels in 2D 
migration experiments. Data was filtered to only account for cells visible during the total 
time of the experiment. Raw data from Trackmate was analyzed using the Chemotaxis 
tool plugin for ImageJ (Ibidi, Germany) to obtain accumulated distance, net distance and 
directionality (ratio of net to accumulated migration distance). Accumulated distance 
represents all the distance travelled by the cell while net distance only represents the 
distance between the initial and final position of the cell. Migration velocity was 
calculated by dividing accumulated distance by total time of migration. Directionality as 
evaluated here makes reference to intrinsic directionality and represents the degree of 








Figure 4.1 Experimental setup to analysis GBM migration in co-culture with stromal 
cells. A. Cell populations are expanded in liquid culture, recovered and labeled with 
different fluorophores for movement tracking. B. Individual cells are tracked over time 
every 1.5h by confocal microscopy. C. Images generated are analyzed to obtain the 
position of every cell on time and calculate the displacement trajectories. D. Initial and 





















4.2.6 Modified 3D co-culture culture method for protein extraction 
GBM cells were embedded in collagen-hyaluronan matrices at a density of 3.5*105 cells 
in 200 µl of matrix and platted in 48 multi-well plates for polymerization. To achieve 3D 
co-culture of astrocytes and GBM that allowed protein extraction of the different 
populations, the polymerized matrix containing the GBM cells was recovered and placed 
in the center of a well in a 24 multi-well plate. Subsequently 200 µl of collagen matrix 
with 3.5*105 astrocytes were pipetted to the surroundings to form a concentric ring with 
the astrocytes layer in the outside and the GBM layer inside. The matrices were incubated 
during 30 min at 37°C to allow complete polymerization. Media containing equal 
amounts of astrocyte and GBM media were added to the culture. Cells were maintained 
at 37°C in an atmosphere of 5% CO2 for 72 h. For protein extraction the concentric ring 
was separated to obtain the layers containing each of the cell populations. 
 
4.2.7 Western Blot analysis 
Cells in 3D culture were washed with ice-cold PBS and incubated with RIPA buffer 
supplemented with 1X Halt™ protease and phosphatase inhibitor cocktail (ThermoFisher 
Scientific, Waltham, MA) at 4°C for 3 h with constant agitation followed by 
centrifugation at 12000 rpm during 20 min to recover the supernatant. Total protein 
concentration was quantified by Pierce BCA protein assay (ThermoFisher Scientific, 
Waltham, MA). Equal amounts of protein samples were denaturalized and loaded in 4-20% 
polyacrylamide gels (Biorad, Hercules, CA). Samples were transfer to PVDF membranes 
(ThermoFisher Scientific, Waltham, MA). Membranes were blocked with Odyssey 




incubated with primary antibody diluted in blocking solution during 12 h at 4°C. 
Afterwards, membranes were washed three times for 3 min each with TBS-T buffer 
(0.075% Tween-20) and incubated with secondary antibody 1 h at room temperature. 
Prior to visualization, membranes were washed 3 times 3 min each with TBS-T buffer. 
Primary antibodies used were β-actin (dilution 1:1000), MMP-9 (1:1000) from Cell 
Signaling (Danvers, MA), and MMP-2 (1:1000), MMP-14 (1:1000) from Abcam 
(Cambridge, UK). Secondary antibodies IRDye800CW anti-rabbit and IRDye680RD 
anti-mouse (Licor, Cambridge, UK) were used at a dilution 1:2000. Visualization was 
performed in Odyssey Clx System (Licor, Cambridge, UK). Quantification of western 
blot band intensity was performed in ImageJ. 
 
4.2.8 Statistical analysis 
All measurements are expressed as mean ± SE unless otherwise stated. Statistical 
analysis was performed in Origin. Comparisons between treatments were made using two 
samples t-test or one-way analysis of variance (ANOVA) with Tukey-Kramer mean 







4.3 Results  
 
4.3.1 GBM migration in 3D brain-like matrix is slower and more directional than in 2D 
rigid surfaces 
 
Despite the increasingly recognized influence of the 3D microenvironment on cell 
adhesion and migration, cell migration is usually evaluated in 2D rigid or semirigid 
platforms by scratch assay or Transwell migration assays. To identify and quantify the 
differences of migration in 2D liquid culture and a 3D matrix platforms we compared 
distance, velocity and directionality (persistence) of migration of three different GBM 
cell lines (GBM10, GBM43 and GBAM1) when cultured on a rigid culture dish (standard 
2D liquid culture) and within a 3D matrix of collagen-hyaluronan that recapitulates 
composition and mechanical properties of GBM ECM. All GBM cell lines studied 
showed greater accumulated migration distance in 2D culture compared to culture in 3D 
Col-HA matrix (Fig 4.2). However, comparison among cell lines showed that non-stem 
GBM lines GBM43 and GBM10 exhibited higher migration distances on 2D platforms 
compared to the stem cell line GBAM1. Interestingly, cell line GBM10 that reached the 
greatest migration distance in 2D exhibited very low migration distances when cultured 
in the 3D matrix. A similar trend was observed for net migration distances, where 2D 
platforms offered a more permissive migration platform compared to the 3D matrix. 
Analysis of directionality of migration showed that directionality of GBAM1 and 
GBM43 was higher in 3D culture compared to 2D culture, this was to be expected given 





Figure 4.2 Migration of GBM in a 3D matrix presents short accumulated and net 
migration distance and higher intrinsic directionality. A. Accumulated distance of 
migration in 15h. B. Migration distance between initial (0 h) and final migration point (15 
h). C. Migration velocity calculated as accumulated distance over total time. D. 
Directionality of migration (accumulated/net distance). Data represent n=400-1500 
individual cells and is presented as boxes indicating first, second and third quartile and 
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4.3.2 Interaction with astrocytes increases GBM migration in 2D culture  
 
Figure 4.3 Astrocytes and GBM cells in 2D co-culture have direct physical contacts. 
Astrocytes present a more extended morphology that covers almost completely the 2D 
surface compared to the GBM cells despite been present at the same density.  
 
As demonstrated, clear differences between migration on 2D surfaces and in 3D matrices 
exist. To gain further insight into differences between 2D and the 3D matrices we next 
tested the effect of astrocytes on GBM migration. We generated a layer of astrocytes on a 
rigid surface and seeded GBM cells on the astrocyte layer. With this experiment we 
attempted to corroborate that astrocytes have the same effect on 3D migration of non-
stem GBM cells as what has been previously observed on GBM stem-like cell migration. 
Observations of the two cell populations in 2D culture, showed a marked difference in 







density, the astrocytes extended their body covering a considerable part of the whole 
surface culture, while the GBM cells presented a predominantly rounded morphology 
with occasionally spindle-like deformation during movement, and could be seen 
spaciously distributed on the surface (Figure 4.3). Migration analysis of all the GBM cell 
lines studied showed that presence of an astrocyte layer increases GBM migration. GBM 
cells were able to reach almost 2-fold greater migration distances (both accumulated and 
net) in presence of astrocytes than cultured alone (Fig 4.4 A, B). To further determine the 
mechanism involved in increased GBM migration due to presence of astrocytes, we 
evaluated migration of GBM cells cultured with astrocyte-conditioned media (ACM). 
Presence of ACM did not increase migration. GBM cells cultured with ACM presented 
similar migration distances to GBM cultured alone in normal media (Fig 4.4 A, B), 
suggesting the dynamic interaction between the two populations caused a greater 






Figure 4.4 Presence of astrocytes but not astrocyte conditioned media increases GBM cell 
migration. A. Accumulated distance of migration during 15 h. B. Net migration distance 
between initial (0 h) and final points of migration (15 h). C. Directionality of migration 
(accumulated over net distance). Bars indicate Mean ± SE from a population of 400-1500 
individual cells. * Represents statistical difference at α=0.05 
 
4.3.3 Presence of astrocytes increases GBM migration in 3D brain-like model 
 
Given the effect of astrocytes presence on 2D GBM migration we further tested whether 
the same effect was observed during 3D culture in a matrix that represents the physical 
and compositional characteristics of the extracellular matrix (ECM) present in the GBM 
microenvironment. Equal numbers of human astrocytes and GBM cells were 































































analyzed. Similar to what was observed in liquid culture, presence of astrocytes increased 
the 3D accumulated and net migration distance of all the GBM cell lines studied (Fig 4.5).  
 
 
Figure 4.5 Presence of astrocytes increase migration of all GBM cultured in a 3D-brain-
like model of collagen-hyaluronan. A. Accumulated distance of migration during 15 h. B. 
Net migration distance between initial (0 h) and final points of migration (15 h). Bars 
indicate Mean ± SE from a population of 400-1500 individual cells, from at least 2 
independent repetitions * Represents statistical difference at α=0.05 
 
In both cases, 2D liquid culture and in 3D-culture, presence of astrocytes increased GBM 
migration. However, is important to note that direct physical contact between the two 
population was certain in 2D (Figure 4.3) culture but not in 3D culture (Figure 4.6). In 
the 3D matrix, GBM and astrocytes were seeded at a concentration in which direct 
physical contact although probable was not predominant. Attempts to increase cell 
concentration to maximize contact as occurs in vivo, resulted in rapid matrix contraction 














Figure 4.6 Co-culture of Astrocytes and GBM cells in a 3D-matrix. Both cell populations 
are homogeneously distributed within the matrix. At the cell density used for 3D culture 
studies the cells generally do not present physical contact with each other. GBM cells 
appear in green and astrocytes in red. Reconstruction of a volume of study with 
dimensions z: 80 µm x: 460 µm y: 460 µm. 
 
4.3.4 3D co-culture of astrocytes and GBM cells affects GBM expression of matrix 
metalloproteinases (MMPs) 
 
Increased GBM migration due to presence of astrocytes has been associated to physical 
interaction between the two cell populations and communication through gap 
junctions.23,112 However, having observed that in 3D co-culture physical contact was not 
predominant, still the migration was higher in presence of astrocytes than during only-
GBM culture, we hypothesized that astrocytes could affect GBM 3D migration by 
increasing the production of proteinases required for ECM degradation. Thus, we tested 











previously linked to GBM migration. Co-culture with astrocytes in the 3D model 
increased GBM production of MMP-9 but has a differential effect on the expression of 
MMP-2 (Fig 4.7). Presence of astrocytes slightly increased GBM10 expression of MMP-
2 (both pro-enzyme at 72 kDa and activated enzyme 66 kDa). In contrast MMP-2 
expression decreased in GBM43 cells in the presence of astrocytes. 
 
  
Figure 4.7 Presence of astrocytes during co-culture with GBM cells in a 3D brain-like 
model increases expression of MMP-9 and has a differential effect on MMP-2 expression 
(MMP-2 pro-enzyme: 72 kDa, MMP-2 active isoform: 66 kDa).  14µg of total protein 
were loaded form each sample. 
 
4.3.5 Dual presence of endothelial colony forming cells (ECFC) and astrocytes 
increases GBM migration on 2D surfaces 
 
The two principal structures used by GBM to migrate across healthy brain parenchyma 
are axonal tracks and blood vessels.56 To evaluate the effect of vasculature-forming cells 
on the migration of GBM we co-cultured endothelial colony forming cells (ECFCs) and 
GBM cells at a ratio 1:1 as a monolayer on 2D surfaces and compared GBM migration 




ECFCs increased the accumulated and net migration of all GBM cell lines. The greatest 
effect of ECFCs on migration was observed in the stem-like cell line GBAM1 where 
presence of ECFCs increased accumulated migration more than 5-fold (Figure 4.8).  
 
Given the increase of GBM migration observed due ECFCs and astrocytes as previously 
shown, we incorporated astrocytes and ECFCs in the same culture with GBM cells (ratio 
1:1:1) to determine a possible synergistic effect of both cell populations on GBM 
migration. Dual presence of ECFCs-astrocytes further increased 2D GBM migration of 
all GBM cell lines evaluated compared to cultures with only presence of ECFC and GBM. 
 
Differential effect of ECFCs on migration of different GBM cell lines, suggests that 
presence of only ECFCs has a greater effect on the migration of the stem-like cell line 
GBAM1 compared to non-stem cell lines GBM10 and GBM43.  In contrast, migration of 
non-stem GBM cells is visibly increased by combined presence of ECFCs and astrocytes 






Figure 4.8 Co-culture with Endothelial colony forming cells (ECFCs) and astrocytes 
drastically increases overall migration of GBM on 2D rigid surfaces. Dual co-culture of 
GBM with ECFCs has great effect on GBAM1 migration but minimal influence on 
migration of GBM10 or GBM43. A. Accumulated distance of migration during 15 h. B. 
Net migration distance between initial (0 h) and final points of migration (15 h). C. 
Directionality of migration (accumulated / net distance). Bars indicate Mean ± SE from a 
population of 400-1500 individual cells. * Represents statistical difference at α=0.05. 
 
4.3.6 Presence of ECFCs and astrocytes has an opposite effect on 3D migration of 
stem-like and non-stem GBM cells 
 
To corroborate that presence of ECFCs and combined astrocytes - ECFCs had a similar 
effect in conditions more similar to in vivo settings; we used the 3D model of GBM ECM 
to analyze GBM migration in presence of ECFCs and astrocytes - ECFCs. Similar to 




























increased the accumulated migration of the non-stem cell lines GBM10 and GBM43, 
however, these co-culture conditions had the effect on the migration of stem-like cell line 
GBAM1 (Figure 4.9). Analysis of net migration shows that in 3D culture, presence of 
ECFCs or ECFC-astrocytes had no effect on the net distance covered by GBAM1; 
suggesting that GBAM1 in co-culture migrates shorter distances but with more 
directionality/persistence. Combined presence of ECFCs and astrocytes increased net 
migration distance of the non-stem cells similar to what was observed in 2D culture. 
 
 
Figure 4.9 Dual presence of astrocytes and ECFCs increases accumulated migration 
distance of non-stem GBM cells (GBM10, GBM43), but decreases migration of the stem-
like GBM cell line GBAM1. A. Accumulated distance and B of migration during 15 h. B. 
Net migration distance between initial (0 h) and final points of migration (15 h). Bars 
indicate Mean ± SE from a population of 400-1500 individual cells. * Represents 
statistical difference at α=0.05. 
 
4.3.7 Presence of stromal cells increases directionality of GBM stem-like cells but 
decreases directionality of non-stem cells during 3D migration  
 
Directionality or persistence of migration is a fundamental characteristic of migration that 
















multiple environmental and intrinsic signals to stabilize or generate more protrusions 
towards specific directions. Analysis of the directionality of migration in 3D culture 
indicated that non-stem GBM cell lines decreased directionality (greater random 
migration) in presence of stromal cells such as astrocytes, ECFCs or combination of both 
(Fig 4.10). However, presence of stromal cells increased considerably the directionality 
of the stem-like GBAM1 cells in the co-cultures evaluated (Fig 4.10). Given that in all 
conditions the properties of the extracellular matrix and the distribution of the stromal 
cells was homogeneous within the matrix, we suggest that presence of stromal cells 
increases intrinsic directionality of GBM stem-like cells but has the contrary effect on 




Figure 4.10 Presence of stromal cells in a 3D model increases migration directionality of 
GBM stem-like cells (GBAM1) but increases randomness of movement of non-stem 
GBM cells. Bars indicate Mean ± SE from a population of 400-1500 individual cells. * 







Aggressive and diffuse invasion across healthy brain parenchyma is characteristic of 
GBM. Despite the great efforts to surgically remove all the tumor cells, in many cases 
residual tumor cells are left in the tissue, mainly due to the impossibility to differentiate 
them from the peritumoral edema present at the margins tumor mass. 
During tumor progression, cancer cells develop a dynamic relationship with the 
microenvironment and alter normal brain cellular functions to form a niche that supports 
tumor growth and expansion.30,53,104,106,113 Here, we investigated the role of different 
components of the microenvironment such as presence of a GBM-like extracellular 
matrix and presence of astrocytes and endothelial cells, on GBM migration. Our results 
indicate that in a 3D environment GBM decreases the overall migration compared to 
standard liquid culture. Moreover, presence of stromal cells in a 3D in vitro tumor model 
increases the migration of non-stem GBM cell lines.  
 
The majority of migration studies have used conventional migration assays on rigid 
surfaces to study cancer cell migration, however tumor cells exist in a 3D environment in 
presence of stromal cells and surrounded by ECM. Comparison of GBM migration when 
cultured in 2D rigid surfaces and within a 3D model of GBM ECM shows that presence 
of a 3D ECM reduces the migration of all GBM cell lines studied and increases the 
intrinsic directionality of the cells. Morphology and cell adhesion have been found to be 
different for cells cultured in 2D surfaces and within 3D matrices.114–116 Differences in 




different fashion the cellular processes involved in migration and ultimately affect 
migration mode, velocity and directionality. 
 
Stromal cells are fundamental components of the tumor microenvironment and 
synergistically interact with cancer cells during tumor progression. Incorporation of 
astrocytes in 2D monolayer culture increased migration distance and velocity of GBM. 
Previous studies by Rath (2013)110 showed that astrocytes and astrocyte conditioned 
media increase migration of GBM stem-like cells in a Transwell assay, but have no effect 
on non-stem GBM cells. In contrast, we observed that presence of only astrocyte 
conditioned media had no effect on increasing migration of non-stem GBM cells but 
direct contact of the populations on a 2D surfaces increased GBM migration. It has been 
recognized that direct communication between astrocytes and GBM through gap 
junctions, and specifically through Connexin 43 (Cx43) increases migration.23,112 
Nevertheless, our results showed that in the 3D model of GBM ECM where cells are 
homogenously distributed and physical contact is not prevalent, incorporation of 
astrocytes also increased GBM migration, suggesting that formation of heterocellular gap 
junctions is not necessary for astrocytic effect on GBM migration.24  
 
Regulation of GBM migration has been directly linked to astrocyte signaling through 
either direct secretion of MMPs40,117 or secretion of neurotropic factors that induce cancer 
MMPs expression. Studies by Le (2003)117 and Wang (2013)40 showed that astrocyte 
expression of pro MMP-2 and pro MMP-9 increased GBM migration. Furthermore, 




cells including astrocytes, enhances migration of cancers like human squamous cell 
carcinoma,118 pancreatic cancer119 and GBM,21 possibly through up-regulation of tumor 
MMP-9 expression. Yet, these studies have been performed in 2D liquid cultures, where 
MMPs expression and activation are affected by the absence of a 3D ECM. We showed 
that presence of astrocytes during 3D culture increases expression of GBM MMP-9. 
Combining our observations with results by Okada (2003),119 we suggest that higher 
expression of MMP-9 by GBM can be linked to astrocytic-secreted GDNF. 
 
The role of endothelial cells in GBM progression has mainly being studied in the context 
of tumor neovascularization through tumor expression of VEGF. However, the link 
between neovascularization and VEGF has been proven to be more complex than initially 
recognized, and extends to multiple tumor processes beyond vascularization. For instance, 
vascular networks are used by GBM as migration highways; however, presence of VEGF 
directly decreases GBM invasion120 and prolonged inhibition of VEGF cause ultimate 
enhanced GBM migration as was observed in patients treated with Bevacizumab.121 
Inhibition of interaction between the tumor and the endothelial cells, as well as inhibition 
of angiogenesis through VEGF-A blockade by Bevacizumab can led to tumor invasion 
and metastasis. The mechanism by which direct blockade of VEGF increases GBM 
invasion is related to the hepatocyte growth factor (HGF) and its receptor MET. 
MET/HGF interaction has been known to activate cell migration, however presence of 
VEGF antagonizes MET/HGF interaction.120 Blockade of VEGF enhances MET/HGF 




Interaction between tumor and endothelial cells has repercussions in multiple tumor 
processes. Despite the fundamental role of endothelial cells as main components of the 
tumor microenvironment, few studies have physically incorporated them into in vitro 
models to study their effect on cancer cell behavior.122 Here, we demonstrated that dual 
presence of endothelial cells and astrocytes increases the migration of non-stem GBM 
cells on 2D and 3D platforms but decreases migration of stem-like GBM cells in a 3D 
model of GBM ECM. Stem-like GBM cells, similar to neural progenitors reside in a 
specific perivascular niche closely associated with blood vessels and endothelial cells.8,35 
Although, stem-like GBM cells can present high migratory potential in other contexts as 
we and others have shown,26,50 we suggest that in presence of an environment that 
mimics the perivascular niche, they present reduced migration as the microenvironment 
provides supportive and maintenance cues. In the same context, presence of stromal cells 
increases the directionality of stem-like GBM cells, but decreases directionality of non-
stem GBM cells. Differences in directionality can be attributed to differential intrinsic 
response of stem-like GBM cells to external guidance cues provided by 
microenvironment that regulates the cellular polarity machinery and stabilizes the cell 







4.5 Summary  
 
We investigated the role of the microenvironment in terms of presence of an ECM and 
stromal cells like astrocytes and endothelial cells on migration of stem-like and non-stem 
GBM cells. Our results demonstrate that presence of a 3D GBM-like ECM decreases 
migration velocity, and distance and increases intrinsic directionality of GBM cells. 
Presence of stromal cells either in dual or triple co-culture with GBM increases the 
overall migration of GBM cells on 2D rigid surfaces. When dimensionality and stromal 
cell are combined to evaluate their effect on GBM migration, presence of stromal cells 
increases migration of non-stem GBM cells, however only astrocytes alone and not 
ECFCs or ECFCs-astrocytes increase migration of stem-like GBM cells. This suggests a 
direct role of endothelial cells on migration inhibition of stem-like GBM cells in a 3D 
culture. In the same line, stromal cells present in a 3D environment decrease the 
directionality of non-stem GBM cells but increase intrinsic directionality of stem-like 
GBM cells. Incorporation of multiple components of the GBM microenvironment in an 
in vitro controllable platform presents a powerful tissue-engineering tool to understand 
how individual and combined factors modulate GBM behavior, and specific process that 









CHAPTER 5. THE 3D MICROENVIRONMENT REGULATES STAT3 
ACTIVATION AND RESPONSE TO DRUG INHIBITION IN GLIOBLASTOMA  
5.1 Introduction  
 
The activity of STAT3, a member of the Signal Transducer and Activator of 
Transcription (STAT) family is modulated by the microenvironment. STAT3 regulates 
multiple cellular processes such as proliferation, survival, angiogenesis and migration 
(Fig 4.1).123 In normal cells, STAT3 is present in the cytoplasm as a non-phosphorylated 
monomer and undergoes transient phosphorylation as a response to intracellular 
activators as EGFR, Src and ERK, as well as extracellular signaling through direct 
interaction with members of the Janus–activated kinases.123–125 Phosphorylation of 
STAT3 can occur in Tyr-705 or Ser-727, however, the majority of STAT3 functions are 
directly related to Tyr-705 phosphorylation. Phosphorylated STAT3 forms active 
homodimers via interaction through the SH2 domains that translocate to the nucleus and 
regulate the expression of multiple genes.  
 
STAT3 has lately attracted interest as a potential cancer target due to its location as the 
convergence point of multiple oncogenic pathways and constitutive activation in more 
than 70% of all cancers.126 Gain of function mutation of STAT3 has not yet been reported. 




In GBM basal STAT3 activation is widely variable; previous studies found that 9 to 83% 
of GBM human tumors evaluated exhibited constitutive phosphorylated STAT3.125 The 
role of STAT3 in gliomagenesis involves multiple cellular processes with survival and 
migration being two of the most intensively studied. Constitutive activation of STAT3 
directly upregulates expression of anti-apoptotic proteins Mcl-1, Bcl-2 and Bcl-XL and 
increases survival.123,124 Likewise, constitutive activation of STAT3 has been linked to 
the conversion of non-stem cells to stem-like cells in breast cancer128 as well as increased 
self-renewal of GBM stem-like cells.129 Effect of STAT3 in migration is linked to 
regulation of cell adhesion and cytoskeletal rearrangement mediated by RhoGTPases. 
STAT3 association with NF-kB mediates glioma migration through the adhesion 
molecule ICAM-1.130 Furthermore, inhibition of STAT3 expression has been shown to 
inhibit the activity of RhoA and reduce phosphorylation of the focal adhesion protein 
FAK as well reduce expression of MMPs.131  
 
Constitutive STAT3 activation in cancers occurs as a response to deregulated cytokine 
and chemokine signaling from the tumor microenvironment. STAT3 activation in cancer 
can in turn be propagated to other stromal and immune cells via expression of signals 
such as vascular endothelial growth factor (VEGF) and interleukin-10 (IL-10).41 
Likewise, the presence of the ECM modulates the cell response to soluble signals,132 and 
increases expression of adhesion molecules such as β1-integrin that induces STAT3 
activation.133 Despite the fundamental role exerted by the microenvironment on STAT3, 
the majority of studies that have evaluated STAT3 oncogenic function were performed in 




STAT3 inhibition has been increasingly considered as possible route for GBM treatment. 
Given the great effect that the microenvironment exerts on STAT3 activation, we suggest 
that the use of in vitro models that recapitulate the characteristics GBM 
microenvironment are one of the most appropriate platforms for the initial assessment of 
drug treatments aimed to target STAT3 in GBM. In this study we investigated the impact 
of the 3D microenvironment comprised by a GBM-like ECM and astrocytes on the basal 
phosphorylation of STAT3, as well as the effect of the STAT3 inhibitor SH-4-54 on 
viability and migration of patient-derived GBM cells. 
 
 


























5.2 Experimental Methods  
 
5.2.1 Standard liquid cell culture 
GBM human–derived cell lines GBM10, GBM43 and MHBT32 were maintained in high-
glucose DMEM (Life Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM 
human cell line GBAM1 (CD133+ >98%) was maintained in DMEM/F12 supplemented 
with B27 without vitamin A (ThermoFisher Scientific, Waltham, MA) and with growth 
factors EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ). Human primary 
astrocytes (ScienCell, Carlsbad, CA) were maintained according to vendor specifications. 
All cell lines were cultured at 37°C in an atmosphere of 5% CO2, fed  with complete 
media every other day and passaged at 70-80% confluence.  
 
5.2.2 Synthesis of 3D brain-like matrix and 3D cell culture 
3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen 
(GeniPhys, Zionsville, IN) at concentration of 2 mg/ml and sodium hyaluronate (MW 
351-600) KDa (Lifecore Biomedical, Chaska, MN) was incorporated at 10 mg/ml as 
described previously. Cells were suspended at the desired concentration in the 3D matrix 
prior polymerization at 37°C for 30 minutes. Complete media was added to the top of the 
matrix, and cells were cultured at 37°C in an atmosphere of 5% CO2. For 3D co-culture 
of GBM and astrocytes, GBM cells were embedded in collagen-hyaluronan matrix at a 
density of 3.5*105 cells in 200 µl of matrix, following polymerization 3.5*105 astrocytes 
suspended in 200 µl of collagen matrix were pipetted to form a concentric ring as 




5.2.3 Drug treatment and cell viability analysis 
GBM cells were cultured for 24h (in liquid medium or within the 3D Col-HA matrix) in a 
96-well plate at 5000 cells/well with 100 µl of complete media prior addition of SH-4-54 
inhibitor in DMSO vehicle. All treatments were normalized to control DMSO volume. 
Viability of GBM cells cultured in liquid media and 3D collagen-hyaluronan matrix was 
assessed by Alamar blue assay (ThermoFisher Scientific, Waltham, MA). After drug 
treatment, cells were incubated with Alamar blue reagent during 3 h and absorbance was 
measured at 570nm. Cells treated only with DMSO served as controls. Absorbance 
readings were normalized to DMSO controls to calculate viability percentages. 
 
5.2.4 RNA interfering assays 
GBM43 and GBM10 were transfected by reverse transfection with STAT3 siRNA (Santa 
Cruz Biotechnology, Dallas, TX). Briefly, 10 pmol of siRNA were diluted in 50 µl of 
OptimMEM medium (ThermoFisher Scientific, Waltham, MA) and mixed with 3 µl of 
Lipofectamine RNAimax (ThermoFisher Scientific, Waltham, MA) in 50 µl of OptiMEM 
media. The mix was incubated at room temperature for 15min and added to a well of a 
24-well plate. Then, 1*105 GBM10 or GBM43 cells suspended in OptiMEM media were 
deposited per well containing the mix to a final volume of 300 µl/well. Cells were 
incubated at 37°C in an atmosphere of 5% CO2 during 24 h and 300 µl of normal DMEM 
media with 20% FBS were added to each well to stimulate cell attachment to the plate. 
Forty-eight hours after transfection cells were recovered by trypsin exposure and cultured 




control-siRNA A and positive control with siRNA FITC conjugate-A (Santa Cruz 
Biotechnology, Dallas, TX). 
5.2.5 Western blot analysis 
Cells cultured in 2D monolayer and in 3D brain-like matrix were were washed with ice-
cold PBS and lysed with RIPA buffer supplemented with 1X Halt™ protease and 
phosphatase inhibitor cocktail (ThermoFisher Scientific, Waltham, MA) at 4°C as 
described in Chapter 3. For protein extraction of GBM co-cultured in 3D with astrocytes 
the concentric ring was manually separated to obtain the layers containing each of the cell 
populations. Total protein concentration was quantified and electrophoresed as described 
in Chapter 3. Blotting of the membranes was done with primary antibodies against 
STAT3-p705 (dilution 1:2000), STAT3-p727 (dilution 1:2000), STAT3 (1:1000), actin 
(1:1000) (Cell Signaling, Danvers, MA). Secondary antibodies IRDye800CW anti-rabbit 
and IRDye680RD anti-mouse (Licor, Cambridge, UK) were used at a dilution 1:2000. 
Visualization was performed in Odyssey Clx System (Licor, Cambridge, UK). 
Semiquantitative analysis of STAT3 activation was done in ImageJ. Bands corresponding 
to phosphorylated STAT3 and total STAT3 were normalized to a ladder band to avoid 
differences in multiple readings of the same membrane. STAT3 activation was quantified 
as phosphorylated STAT3 over total STAT3. 
 
5.2.6 Migration on 2D surfaces 
Cells were tested for viability, stained with CellTracker™ Green CMFDA dye (Life 
Technologies, Carlsbad, CA) for visualization and plated in a µ-slide angiogenesis 




incubated during 4 h for attachment. Afterwards, cells were placed in an on-stage 
incubator and treated with the SH-4-54 prior initiation of time-lapse confocal microscopy 
during 15 h every 1.5 h. 
 
5.2.7 Migration in 3D brain-like matrix 
GBM cells were stained with CellTracker™ Green CMFDA dye (Life Technologies, 
Carlsbad, CA) and embedded at a density of 1*106 cells/ml within the collagen-
hyaluronan matrix before polymerization. Volumes of 30 µl of matrix per well were 
platted in a µ-slide angiogenesis chamber (Ibidi, Germany). After matrix polymerization, 
30 µl of media was added per well and cells were maintained at 37°C in an atmosphere of 
5% CO2 for 24 h, prior migration analysis. Drug SH-4-54 was added to the cultures 
15min prior the initiation of migration analysis. During migration cells were imagined by 
time-lapse confocal microscopy every 1.5 h during 15 h.  
 
5.2.8 Time-lapse confocal imaging, analysis of migration and statistical analysis 








5.3 Results  
 
5.3.1 Basal status of STAT3 in GBM during 2D liquid culture 
 
Given the wide range of basal activation found in multiple GBM tumors, we initially 
tested the status of STAT3 on tyrosine 705 and serine 727, the two phosphorylation sites 
of STAT3 to check the constitutive status of STAT3. Cell lines GBM10, GBM43 and 
GBAM1 showed very low to absent basal phosphorylation of Tyr-705 or iSer-727, while 
the cell line MHBT32 presented basal phosphorylation in both active sites (Fig 5.2). 
Given the low basal STAT3 activity in some cells, we stimulated with interleukin-6 (IL-
6), a well-recognized inducer of STAT3 activation, and checked the phosphorylation 
status at varied timed after stimulation to account for the transient response characteristic 
of STAT3. We observed that IL-6 stimulus induced Tyr-705 phosphorylation in the non-
stem cell lines GBM10, GBM43 and MHBT32 but not in the stem-like line GBAM1 (Fig 
5.2). As expected the activation was transient; phosphorylation occurred almost 
immediately after stimulus and was maintained during the first hour but considerably 
decreased by 2 h post stimulation. IL-6 did not cause phosphorylation of STAT3 on Ser-







Figure 5.2 STAT3 is constitutively activated (Tyr-705 and Ser-727) in MHBT32 but not 
in GBM10, GBM43 and GBAM1. IL-6 stimulation caused transient phosphorylation of 
STAT3 in all non-stem GBM cell lines but not in the stem-like GBAM1. Upper 
horizontal section presents phosphorylation of Tyr-705 and lower section presents 
phosphorylation on Ser 727. Total protein loaded per lane 12 µg GBM10, 13 µg 
MHBT32 and 16 µg GBM43 and GBAM1. 
 
5.3.2 GBM cells present constitutive STAT3 activation during culture in a 3D-model of 
tumor microenvironment 
 
Following the low basal activation in vitro by most of the GBM cell lines studied, and 
based on the regulation that the microenvironment exerts on cellular behavior, we 
evaluated basal STAT3 status in GBM when cultured in a 3D GBM-like ECM alone or in 
presence of astrocytes.  All GBM cells cultured in the 3D model exhibited basal 
activation of STAT3 although in differing degrees (Fig 5.3). GBM10, GBM43 and 
GBAM1 that previously displayed very low to absent STAT3 basal activity, exhibited 
high STAT3 activation in 3D culture. MHBT32 exhibited lower STAT3 activation and 
general lower total STAT3 in 3D culture compared to 2D culture, yet basal activity was 
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present in 3D culture. Interestingly, presence of astrocytes in the 3D-model did not 
significantly alter STAT3 activation in non-stem cell lines, however in the stem-like cell 
line GBAM1 increased basal STAT3 activation by two-fold (quantification using ImageJ); 
suggesting that combined effect of ECM and stromal cells drastically alters the basal 
status of STAT3 in GBAM1 compared to regular 2D liquid culture. 
 
 
Figure 5.3 GBM exhibits basal activation of STAT3 when cultured in a 3D matrix that 
recapitulates characteristics of GBM ECM. Presence of astrocytes in 3D environment 
increases by 2X basal STAT3 phosphorylation of GBAM1 compared to 3D culture 
without astrocytes. Total protein loaded per lane from 2D culture: 12 µg GBM10, 13 µg 
MHBT32 and 16 µg GBM43 and GBAM1, from 3D culture 14 µg GBM10, GBM43, 
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5.3.3 STAT3 inhibitor SH-4-54 decreases viability of stem-like GBM cells but has 
minor effects on viability of non-stem GBM cells 
 
STAT3 is involved in the regulation of multiple cell processes including apoptosis and 
cell proliferation. Based on our previous results that show differential basal activity of 
STAT3 mediated by the microenvironment, we assessed the effect of STAT3 inhibition 
on GBM survival, both in 2D liquid and 3D culture. To this end we treated GBM with 
varied concentrations of the small molecule STAT3 inhibitor SH-4-54, which binds to the 
SH2 domain of STAT3 preventing phosphorylation and dimerization. In liquid culture, 
SH-4-54 reduced cell viability of MHBT32 to 60% at concentrations as low as 5 µM, as 
was expected given its basal activation of STAT3 (Fig 5.4). The effect of SH-4-54 on 
GBM43 and GBM10, which did not present basal activation of STAT3 was minor. The 
drug only decreased viability of GBM43 to 65% at 25 µM and not had any effect on 
GBM10 viability. Interestingly, SH-4-54 was very effective in reducing viability of the 
stem-like line GBAM1; concentrations as low as 2 µM reduced GBAM1 viability to 
nearly 40%. Evaluation of the anti-STAT3 drug SH-4-54 in 3D culture showed less or 
similar effect on GBM viability despite the fact that all lines presented basal activity of 
STAT3 in 3D culture. Similar to what was observed in liquid culture, GBM10 was 
unresponsive to treatment. MHBT32 that exhibited high sensitivity to SH-4-54 in 2D 
culture presented no reduction in viability after treatment in 3D culture. Only GBM43 
and GBAM1 cell lines exhibited viability decrease when treated with the inhibitor in 3D 
culture. Overall, anti-STAT3 treatment was very effective at low concentrations in 





Figure 5.4. GBM viability after anti-STAT3 treatment with SH-4-54. Stem-like GBAM1 
cell line exhibited the highest sensitivity to SH-4-54, however the non-stem GBM cells 
were less responsive to treatment, especially GBM10. Treatment in 3D was less efficient 
in decreasing viability compared to treatment in liquid culture. 
 
5.3.4 Inhibitor SH-4-54 decreases STAT3 phosphorylation in GBM43 but not in 
GBM10 
 
The varied results obtained when assessing the effect of SH-4-54 inhibitor on GBM 
viability suggested dissimilar activity of the inhibitor on the various cell lines. To 
corroborate that SH-4-54 was indeed inhibiting STAT3 phosphorylation, we tested the 
SH-4-54-resistant cell line GBM10 and the SH-4-54-sensitive cell line GBM43 by 
pretreating with increasing doses of SH-4-54 and subsequently stimulating STAT3 
activation with IL-6. Unfortunately, testing of GBAM1 was not possible due lack of basal 
STAT3 activation as well as unresponsiveness to IL-6 or EGF (data not shown) 
stimulation.  SH-4-54 did not inhibit STAT3 Tyr-705 phosphorylation in GBM10 at any 
concentration evaluated (2-10 µM) (Fig 5.5), agreeing with the unresponsiveness 





















































STAT3 inhibitor SH-4-54 (µM)
*
C






















































































































































STAT3 inhibitor SH-4-54 (µM)
*
C




























observed in the survival tests. In contrast, the drug effectively inhibited STAT3 Tyr-705 
phosphorylation in GBM43 cells and the degree of inhibition was proportional to the 
concentration of drug evaluated. 
 
 
Figure 5.5 STAT3 inhibitor SH-4-54 effectively decreases STAT3 Tyr-705 
phosphorylation in GBM43, but has no effect on STAT3 activity in GBM10. Total 
protein loaded per lane 7 µg GBM10, 14 µg GBM43. 
 
5.3.5 Inhibitor SH-4-54 decreases STAT3 migration of GBM43 but not in GBM10 in a 
3D-model of GBM microenvironment 
 
STAT3 regulates multiple genes involved in invasion and metastasis. We therefore, 
tested the effect of STAT3 inhibition on migration of GBM10 and GBM43 on 2D 
surfaces as well as in 3D brain-like matrix. Expression of STAT3 was inhibited by 
siRNA in both lines as a control to validate the effect of STAT3 inhibition on migration. 
Analysis of GBM10 and GBM43 migration distance in 2D surfaces showed that 
knockdown or inhibition of STAT3 with SH-4-54 did not reduce GBM migration (Fig 
5.6).  In contrast, anti STAT3 treatments (STAT3 siRNA and SH-4-54) reduced the 









migration of GBM43 in 3D culture. Interestingly, anti-STAT3 treatments did not the 
migration of GBM10 cell line in the 3D model. Although, siRNA knockdown was only 
60% in GBM10, the previous unresponsiveness of this particular cell line to the SH-4-54 
inhibitor combined with unaffected survival and migration after treatment suggest a 
possible impairment of STAT3 function. Our results show that SH-4-54 inhibitor 
effectively decreases STAT3 activation in the GBM43 cell line and such inhibition 
directly correlates with decreased survival and migration in 3D environments. 
 
Figure 5.6 Inhibitor SH-4-54 decreases STAT3 migration of GBM43 but not of GBM10 
in a 3D model of GBM microenvironment A.B. Targeting of STAT3 activation either 
using the small molecule SH-4-54 or siRNA did not affect migration of glioblastoma on 
2D rigid surfaces. C. GBM10 migration in a 3D environment was not decreased by 
STAT3 targeting D. GBM43 decreased 3D migration after STAT3 siRNA knockdown 


























































































































































































STAT3 is an attractive target for GBM treatment given its convenient location as a cross 
point of many oncogenic pathways.126 STAT3 activation is mediated by signaling from 
the microenvironment; nonetheless, the majority of STAT3 studies in GBM have been 
performed in liquid platforms that do not recapitulate the main features of the tumor 
microenvironment and might therefore lead to observations not representative of in vivo 
context. In this study we demonstrated that presence of 3D microenvironment regulates 
the basal activation of STAT3 in GBM and influences the effect of anti-STAT3 drug 
treatment on survival and migration. 
Multiple studies have shown constitutive activation of STAT3 in GBM tumor samples; 
however, basal activation in GBM can be highly variable.123 Evaluation of STAT3 basal 
activity of four patient-derived GBM cell lines showed that during culture in standard 
liquid platforms, the GBM cell lines GBM10, GBM43 and the stem-like cell line 
GBAM1 do not present constitutive phosphorylation of STAT3 in Tyr-705 or Ser-727, 
the two active phosphorylation sites of STAT3. Only the line MHBT32 showed 
constitutive activation of STAT3 in Tyr-705 and Ser-727.  
STAT3 undergoes transient activation as a response to microenvironment signals such 
IL-6 family cytokines and certain growth factors as endothelial growth factor (EGF). 
Non-stem cell GBM lines were responsive to IL-6 stimulation and underwent transient 
phosphorylation in Tyr-705, but not in Ser-727. STAT3 phosphorylation triggered by IL-




Primary association of STAT3 and regulation of main processes as survival, proliferation 
and invasion occurs though phosphorylation of Tyr-705, while phosphorylation of Ser-
727 potentiates Tyr-705 activation and controls metabolic activity.134,135 Differential 
activation of Tyr-705 and not Ser-727 can be associated with the short-lived stimulus 
applied that activates only the primary phosphorylation in Tyr-705 but is not sustained or 
strong enough to trigger phosphorylation of Ser-727 in our experimental settings.  
IL-6 is the most well known activator of STAT3. Interestingly, stimulation with IL-6 did 
not trigger phosphorylation of STAT3 in the stem-like GBAM1. STAT3 activation has 
been shown essential for maintenance of stem properties of the cancer stem-like 
population through direct repression of genes involved in differentiation.136 Furthermore, 
studies by Wang (2009)137 showed that direct stimulation of GBM stem-like 
neurospheres with IL-6 increases activation of STAT3. IL-6 stimulation of the stem-like 
line GBAM1 did not induce STAT3 activation as expected, however many factors could 
have influence such outcome, for instance the lack of expression of IL-6 receptor. Further 
studies are needed to understand the characteristics of this cell line in terms of STAT3 
activation. 
STAT3 functions as a signal transducer and is responsive to signals from the 
microenvironment. In agreement, with previous studies regarding the fundamental role of 
the microenvironment in STAT3 activation in cancer, incorporation of GBM cells in a 3D 
model that recapitulates the properties of the brain extracellular matrix induced STAT3 
basal activation. Further incorporation of astrocytes into the 3D ECM model increased 




recapitulation of the tumor microenvironment induces GBM basal STAT3 activation, 
however, when the cells are isolated from their niche, as happens during standard 2D 
culture, STAT3 basal activations is lost, and only GBM cells that harbor a mutation in an 
upstream regulator show constitutive STAT3 activity. 
Effect of inhibition of STAT3 phosphorylation by the small molecule SH-4-54 has been 
effective to reduce survival of brain tumor initiating cells, both in liquid culture and in in 
vivo models.90 Our observations corroborate the effectiveness of SH-4-54 reducing 
viability of the stem-like line GBAM1 both in 2D liquid culture and in 3D culture, 
despite the lack of basal activation in 2D culture previously observed. These results, 
validate STAT3 inhibition as an effective treatment for targeting stem-like GBM 
populations regardless of the basal activation status of STAT3. Our results also agree 
with previous studies that emphasize the importance of STAT3 on proliferation and 
survival of GBM stem-like cells. STAT3 function is essential non only for maintenance 
of stem embryonic cells138 but also for survival of GBM stem-like cells.99,129,139 
Nevertheless, SH-4-54 was less efficient in decreasing viability of non-stem GBM cells.  
 
GBM viability after treatment with the inhibitor SH-4-54 showed that the effect of the 
drug was greater in liquid culture despite the lack of basal STAT3 phosphorylation of 
most of the cell lines studied. Interestingly, SH-4-54 showed less efficiency in decreasing 
the viability of GBM cells in 3D culture despite the fact that all GBM cell lines showed 
basal activation of STAT3 during 3D culture. The varied response of non-stem cells to 




phosphorylation. Our results showed that SH-4-54 effectively inhibits Tyr-705 STAT3 
phosphorylation in GBM43 but not GBM10, suggesting that is potential as GBM 
treatment is cell line dependent.  
 
STAT3 regulation not only regulates survival and proliferation but also migration. 
Activation of STAT3 in cancer cells induces up-regulation of p21, RhoA, matrix 
metalloproteinases (MMPs) and phosphorylated FAK,131 all modulators of cancer 
invasion. Previous studies have shown that silencing of STAT3 impairs migration of 
gastric carcinoma cells131 and GBM cells.136,140 In our studies, knockdown of STAT3 
with siRNA and treatment with SH-4-54 migration of GBM43 in 2D. In contrast, the 
same anti-STAT3 treatments reduced the migration of GBM43 cells in a 3D environment, 
supporting previous studies that have shown a reduction of 3D GBM migration after 
STAT3 targeting.141 The differential effect of anti-STAT3 treatment on 2D and 3D 
migration can be related to different basal STAT3 activation exhibited by GBM when 
cultured in different platforms. We suggest that in 2D platforms targeting of STAT3 has 
no visible effect given the lack that basal phosphorylation, while in 3D environments 
STAT3 is constitutively active and direct targeting of STAT3 visibly reduces the ability 






5.5 Summary  
 
STAT3 is activated by signaling from the microenvironment and regulates various 
cellular processes implicated in gliomagenesis. Nevertheless, STAT3 function is usually 
studied in absence of the main components of the tumor environment. In this study, we 
investigated the effect of the 3D microenvironment on the basal activation of STAT3 and 
the effect of anti-STAT3 drug treatment on survival and migration of GBM. Our results 
demonstrate that presence of a 3D ECM induces GBM basal activation of STAT3 in cells 
lines that do not show constitutive STAT3 activation during 2D culture. Treatment of 
GBM cells with the STAT3 inhibitor SH-4-54 greatly reduces viability of stem-like GBM 
cells but has a weaker effect on reducing viability of non-stem cell lines. Further 
exploration of SH-4-54 function revealed that this drug effectively inhibits 
phosphorylation of the non-stem GBM line GBM43 but has no visible effect on GBM10. 
Evaluation of the STAT3 inhibition revealed that anti-STAT3 treatment decreases the 
migration in 3D environments for the SH-4-54-responsive line GBM43 but not for the 
SH-4-54-resistant line GBM10. Our results demonstrate the importance of the 3D 
microenvironment on basal status of STAT3 in GBM. As a consequence, STAT3 
inhibition has different effects on survival and migration when evaluated in 2D surfaces 





CHAPTER 6. CONCLUSIONS AND FUTURE WORK 
In this study we explored the influence of the 3D extracellular matrix and stromal cells on 
the regulation of glioblastoma migration and drug response. Initially we addressed the 
effect of the extracellular matrix properties of the migration characteristics of 
glioblastoma neurospheres during 3D culture. By developing a composite matrix of 
hyaluronan  structurally supported by a collagen I oligomer that simulates the brain-
tumor extracellular  matrix composition and comparing with standard, Matrigel and 
collagen type-I monomer matrices, we showed that glioblastoma cells altered their 
migration  mode and velocity depending on the matrix composition and mechanical 
properties. Compositional characteristics of the extracellular matrix as presence of 
hyaluronan  reduced velocity and number of migratory cells, and physical features such 
as stiffness or presence of topographical cues modulated the migration mechanisms 
adopted by the cells. Further efforts to increase the complexity of the developed brain-
tumor extracellular  matrix towards a more similar platform to in vivo tissues, showed 
that incorporation of stromal cells (astrocytes and endothelial cells) modulate 
glioblastoma behavior. Presence of astrocytes reduced the cytotoxic effect of 
temozolomide on glioblastoma stem cells compared to liquid culture only-GBM 3D 
culture. Combined presence of astrocytes and endothelial cells in the 3D model of brain-




presence of endothelial cells (ECFCs) decreased the migration ability of GBM stem-like 
cells suggesting a possible role of endothelial cells on signalining cues to decrease the 
migration activity stem-like GBM cells.  
Use of the 3D model of brain-tumor microenvironment showed that the 
microenvironment induced basal activation of STAT3 in glioblastoma that was not 
evident during standard 2D culture. Therefore, making the 3D model of GBM 
microenvironment a more appropriate platform for the analysis of anti-STAT3 drug 
treatments.  Moreover, presence of the extracellular matrix decreased the cytotoxicity of 
STAT3 inhibition on glioblastoma and allowed a more mechanistic evaluation of the 
effects of STAT3 inhibition on 3D glioblastoma migration.  
 
The unique, multiparameter understanding of the 3D tumor microenvironment has 
revealed striking aspects on cancer migration ranging from highlighting the importance 
of ECM composition and physical properties to the modulation of GBM migration mode 
and drug-response in the presence of stromal cells. Further steps building on the 3D 
tumor microenvironment model present an exceptional opportunity for the generation of 
effective therapies that can keep the pace of the challenges imposed by the always-
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